Using light to control and investigate cell biology by Khamo, John S.
  
 
 
 
USING LIGHT TO CONTROL AND INVESTIGATE CELL BIOLOGY 
 
 
 
 
 
 
 
BY 
 
JOHN S. KHAMO 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Biochemistry 
in the Graduate College of the  
University of Illinois at Urbana-Champaign, 2019 
 
 
 
Urbana, Illinois 
 
 
 
Doctoral Committee: 
  
 Assistant Professor Kai Zhang, Chair 
 Assistant Professor Erik Procko 
 Professor David J. Shapiro 
 Professor Jing Yang 
 
 
 
 
ii 
 
ABSTRACT 
 
 It is no surprise that light plays an important role in life. With the development of modern 
technologies, light has also proven to be a powerful tool for the interrogation of molecular and 
cellular biology. Beyond its use in microscopic applications, light has emerged as an attractive 
modulator of cellular function. Within the last two decades, scientists have begun to harness the 
power of light and light-sensitive moieties to synthetically alter molecular processes in living 
cells. In combination with more conventional experimental techniques, this approach has 
allowed for the precise elucidation of many biological mechanisms that underpin development 
and disease. Here, I report on recent advances in optobiological techniques and their application 
in cell biology. I also include a novel study on the optogenetic delineation of growth factor 
signaling in neuronal development. Finally, I report on the spectroscopic analysis of fluorescent 
nanoparticles with potential biological utility. 
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CHAPTER 1: APPLICATIONS OF OPTOBIOLOGY IN INTACT CELLS AND MULTI-
CELLULAR ORGANISMS 
This work contains previously published material.* 
 
Abstract 
Temporal kinetics and spatial coordination of signal transduction in cells are vital for cell fate 
determination. Tools that allow for precise modulation of spatiotemporal regulation of 
intracellular signaling in intact cells and multicellular organisms remain limited. The emerging 
optobiological approaches use light to control protein-protein interaction in live cells and 
multicellular organisms. Optobiology empowers light-mediated control of diverse cellular and 
organismal functions such as neuronal activity, intracellular signaling, gene expression, cell 
proliferation, differentiation, migration, and apoptosis. In this review, we highlight recent 
developments in optobiology, focusing on new features of second-generation optobiological 
tools. We cover applications of optobiological approaches in the study of cellular and organismal 
functions, discuss current challenges, and present our outlook. Taking advantage of the high 
spatial and temporal resolution of light control, optobiology promises to provide new insights 
into the coordination of signaling circuits in intact cells and multicellular organisms. 
 
 
 
 
 
                                                 
* Khamo, J.S. et al. (2017). Applications of Optobiology in Intact Cells and Multicellular Organisms. J Mol Biol 
429, 2999-3017. Reference 200. 
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Introduction 
Spatiotemporal coordination of gene expression and signal transduction during developmental 
processes 
Despite the variety of cellular processes occurring during embryonic development, only a 
handful of signaling pathways, namely the Notch, Wnt/β-catenin, Sonic Hedgehog (SHH), 
transforming growth factor β (TGFβ), bone morphogenetic protein (BMP), and fibroblast growth 
factor (FGF) signaling pathways, are repeatedly used to regulate early embryonic development 
and differentiation 1. How can a limited number of signaling pathways regulate such diverse cell 
behavior? Mounting evidence suggests that spatial and temporal regulation of these signaling 
pathways is crucial to cell fate determination during development. The same pathways can be 
turned on or off at different times and locations to regulate distinct cell functions. 
Circadian oscillators play a critical role in coordinating temporal kinetics of gene 
expression and signal transduction, responding to signals with a periodicity of 10-24 h. In 
contrast, oscillation with a shorter periodicity, referred to as ultradian oscillation, determines 
many biological events at shorter timescales 2. Temporal coordination of ultradian oscillation 
often correlates with the formation of spatial patterns of tissue structures during development. 
For instance, cyclical activation of the Notch pathway is crucial for the formation of a “salt and 
pepper” pattern of ciliated cells during ciliogenesis 3. Similarly, oscillation of Notch activation is 
required for the formation of somites, the precursors to a variety of segmental structures such as 
the peripheral spinal nerves, vertebrae, axial muscles and early blood vessels 4,5. The period of 
the ultradian oscillations in somitogenesis varies from 20 min in zebrafish to 4-6 hours in 
humans 6. Besides oscillation, variations in the duration of signals can also lead to distinct cell 
fates. For instance, transient and sustained activation of the extracellular signal-regulated kinase 
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(ERK) pathway leads to PC12 cell proliferation and differentiation, respectively 7,8. In pairs of 
genetically identical MCF-10A sister cells treated with EGF, cells entering S phase experience 
sustained ERK activity, whereas the lagging sister cells exhibit pulsatile ERK activity 9. In 
cultured rat hippocampal neurons, acute delivery of brain-derived neurotrophic factor (BDNF) 
elicits transient TrkB signaling and promotes neurite elongation, whereas gradual delivery of 
BDNF elicits sustained TrkB signaling and promotes neurite branching 10. Interestingly, high-
frequency neuronal stimulation can convert a transient BDNF-TrkB activity into a sustained one 
11. Thus, spatiotemporal coordination of gene expression and signal transduction provides a 
fundamental molecular mechanism to regulate cell fates. 
Both biochemical feedback and molecular stability influence signal oscillation and 
duration. For instance, negative feedback between the Hes1 protein and its mRNA leads to 
oscillatory or sustained Hes1 protein expression, resulting in the proliferation and differentiation 
of neural progenitor cells, respectively 12,13. Negative feedback loops in the mitogen-activated 
protein kinase pathway can lead to sustained oscillation in kinase activity 14-16. In the case of 
molecular stability, an increase in the half-life of Hes1 mRNA leads to an extension of the Hes1 
protein oscillation period 17. Unraveling such intricate signaling mechanisms demands tools to 
probe these dynamic regulatory processes with spatiotemporal precision. 
 
Challenges in spatiotemporal control of signal transduction and gene expression 
Our current understanding of gene expression and signaling mechanisms has primarily 
relied on conventional genetic and pharmacological approaches. Commonly used genetic 
approaches such as gain- and loss-of-function mutagenesis often lead to constitutive activation or 
inactivation of signaling activity. To address this issue, alternative chemical and genetic tools 
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have been developed. For instance, several inducible systems are available to activate or repress 
protein expression in yeast 18. Chemical regulation of gene expression has been achieved using 
promoters that respond to molecules such as galactose, methionine, and copper. Alternatively, 
engineered gene regulatory systems that employ estrogen or doxycycline can be utilized for 
orthogonal gene transcription control. While these inducible systems have greatly facilitated the 
control of gene expression, their off-target effects, ineffective delivery, and limited reversibility 
have restricted their use in live cells and multicellular organisms 19-21. Moreover, it remains 
challenging for these conventional approaches to precisely perturb gene expression and signal 
transduction at a resolution that matches the spatial and temporal scales of endogenous 
developmental events, which can occur in minutes within space of several microns. 
 
Emerging optobiological approaches  
Light can be confined to a sub-micron space and precisely tuned in time, with minimal 
invasiveness to biological organisms. These advantages initially enabled the interrogation of 
neuronal firing by light-sensitive synthetic ion channels 22 and channelrhodopsin 23,24 in 
genetically dissected circuits, which led to the coining of the term “optogenetics” 25. By 
modulating neuronal firing, optogenetics has provided a new way to investigate neuronal circuits 
and to establish causal relationships between brain activity and health and disease 26,27. These 
powerful tools not only help researchers in basic science understand signaling circuits in brain 
functions such as learning and memory, but also show promising preclinical and clinical 
potential for rewiring neuronal circuits to amplify or override specific neuronal phenotypes. 
Indeed, optogenetics has been extended to basic and preclinical research on a wide spectrum of 
topics such as Parkinson’s disease 28, sleep 29, cardiac function 30,31, neuropsychiatric diseases 32, 
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epilepsy 33, and sight-restoring therapy 34,35. This new modality provided by light has been 
transforming neuroscience research, as evidenced by its explosive growth in recent years. 
The power of light to interrogate cell functions, however, is not limited to the modulation 
of the membrane potential of excitable cells 36. Light has also been used to control a variety of 
signaling processes 37-43. As pointed out earlier by Lin et al., we believe it is more appropriate to 
refer to this broader emerging field as optobiology, in which light enables new modalities to 
study biological processes in intact cells and multicellular organisms, including in situations 
where genetic dissection is not essential 44. In optobiology, light not only serves as an 
observational tool to follow biological events, but also as a manipulative device to modulate 
activation states of signaling components with high spatial and temporal resolution. 
Over the past decade, a portfolio of optobiological tools has emerged to regulate protein-
protein interactions in live cells. The core components of optobiology are photoactivatable 
proteins, which respond to visible or infrared light stimulation by changing their conformations 
45. These light-triggered conformational changes can induce inter- or intra-molecular 
interactions. When linked to specific signaling components, photoactivatable proteins allow for 
light-controlled activation or inactivation of target signal transduction. To date, light has been 
used to control cellular processes such as gene transcription, translation, protein degradation, 
differentiation, apoptosis, and migration, as discussed in the following sections. Photocaged 
small molecules or amino acids also enable light-mediated control of cell functions, a process 
often referred to as photopharmacological or optochemical control. 
Recent optobiological work has expanded its host system from cultured cells to 
multicellular organisms. Compared to cultured cells, multicellular organisms require better 
quality control in genetic and protein engineering, as well as material and light delivery. In this 
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review, we outline recent advances in optobiology, focusing primarily on accomplishments made 
in the past three years. For earlier work, interested readers are encouraged to refer to previous 
reviews 46-54. In the following sections, we describe optobiological tools with new photophysical 
properties, update new optobiological applications in intact cells and multicellular organisms, 
discuss challenges in optobiology, and present our outlook. Because many reviews have covered 
optogenetic control of neuronal activity based on channelrhodopsin and their derivatives 55-61, we 
will not repeat that aspect of optobiology in this work. 
 
New features of second-generation optobiological tools 
Optobiology offers a repertoire of light responsive modules. Because the commonly used 
phytochrome, cryptochrome, and light-oxygen-voltage (LOV) domains have been extensively 
reviewed 45-49, we only list new members of photoactivatable proteins discovered within the past 
three years (Table 1). We summarize key characteristics of these proteins, including their sizes 
and photophysical properties, namely the excitation wavelength, association and dissociation 
kinetics, and binding affinity. Most of these new members evolved from their first-generation 
parental proteins. Like their parental proteins, these new photoactivatable proteins alter their 
intra- or inter-molecular interactions upon light illumination. Their mechanisms of action and 
new features are depicted in Figure 1. 
 
Table 1: Collection of photoactivatable proteins and their photophysical properties. 
Photoactivatable 
protein 
Parental 
protein 
Excitation 
λ (nm) 
Size 
(a.a.) 
Asso. 
time  
Disso. 
time  
Kd Ref. 
pdDronpa1 
variants1 
Dronpa 
K145N 
500/400 224 3 s2 8 s 4 µM 69 
CRY2-CIB1 
variants3 
CRY2wt 450-490 535/81 
or 170 
ms 2.5-24 
min 
Not 
reported 
70 
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Table 1 (cont.) 
Photoactivatable 
protein 
Parental 
protein 
Excitation 
λ (nm) 
Size 
(a.a.) 
Asso. 
time  
Disso. 
time  
Kd Ref. 
CRY2E490G CRY2wt 450-490 498 ms 23.1 min Not 
reported 
71 
CRY2clust CRY2wt 450-490 507 <1 s ~220 s Not 
reported 
72 
iLID nano & 
micro 
AsLOV2-
SsrA 
SspB 
450-490 149/112 <30 s <30 s 0.1 -
47.0 
µM4 
63 
LOVTRAP AsLOV2 
Zdk 
450-490 146/65 <30 s 1.7-496 
s 
17 nM 
–  >4 
µM5 
65 
Magnets VVD 450-490 150 1.5 s 6.8 s - 
4.7 h 
Not 
reported 
68 
CBD CarH 545 200 Not 
reported 
Not 
reported 
Not 
reported 
73 
VfAU1-LOV n/a 470 150 <1 min 625 s Not 
reported 
67 
CPH1S CPH1 660/720 513 Not 
reported 
 
Not 
reported 
Not 
reported 
77 
BphP1-PpsR2 BphP1 & 
RpPpsR2 
740/636 731/464 3.5-28 
s6 
3-21 s7 
and 170 
s8 
Not 
reported 
75 
1pdDronpa1: Dronpa M40I V60A E121R V123T K145N N158V; pdDronpa1.2: pdDronpa1 
V158I 
2 Kinetics based on fluorescence readout in live cells. 
3 CRY2 535 (a.a. 1-535 of CRY2), tighter light control than CRY2PHR; CIB81 (a.a. 1-81 of 
CIB1) smaller fragment that retains interaction with CRY2; CRY2(L348F), prolonged 
dissociation half-life of 24 min; CRY2(W349R), shortened dissociation half-life of 2.5 min.   
4 iLID nano, blue light lit affinity 132 nM, dark affinity 4.7 µM; iLID micro, blue light lit affinity 
800 nM, dark affinity 47 µM. 
5 Zdk1 blue light lit affinity > 4 µM, dark affinity 26.2 nM; Zdk2 blue light lit affinity 761 nM, 
dark affinity 17 nM; Zdk3 blue light lit affinity 537 nM, dark affinity 11.4 nM.  
6 Exact association kinetics depends on the power of 740-nm light. Stronger excitation light 
reduces the half-time. 
7 Exact dissociation kinetics depends on the power of 636-nm light. Stronger excitation light 
reduces the half-time. 
8 Values are based on dark-conversion kinetics. Irradiation with 636-nm light restores 80% Pfr 
absorbance, the rest 20% depends on dark conversion. 
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Figure 1. Mechanism of action and new features of various newly developed photoactivatable 
proteins. Engineered through their parental proteins, these new optobiological tools retain their 
responses to visible and near IR light stimulation. 
 
New members of LOV-based tools 
Avena sativa light-oxygen-voltage 2 (AsLOV2), a photoactivatable protein commonly 
used in caging a protein of interest, has been engineered to create light-inducible dimerizers, 
including (1) the tunable light-controlled interacting protein tags (TULIPs) 43 and (2) light-
inducible dimers (LIDs). Both utilize the blue light-induced uncaging of a peptide concealed in 
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the C-terminal Jα helix of AsLOV2. TULIPs consist of a peptide epitope attached to serial 
truncations of the Jα helix (LOVpep), which binds to an engineered Erbin PDZ domain (ePDZ) 
upon blue light illumination. Binding affinity between LOVpep and ePDZ can be tuned by 
AsLOV2 mutants that either increase or decrease helix docking. The original LID (oLID) 62 
utilized the similarity between a bacterial peptide, SsrA, and the Jα helix in AsLOV2 to cage 
SsrA from its binding partner protein, SspB. Blue light-induced conformational changes in 
AsLOV2 exposed SsrA, which was then free to interact with SspB. The oLID system is limited 
by a relatively small dynamic range (8-fold change in affinity between lit and dark states) and a 
high dark-state affinity (800 nM). Guntas et al. sought to improve the dynamic range of LID by 
phage display screening and found two improved LIDs, iLID nano and iLID micro 63. Together 
with TULIPs, iLID nano and micro provide a wide range of lit and dark state affinities to be 
utilized in specific cellular applications 64. 
Another new application of the AsLOV2 is to induce protein dissociation by light as 
opposed to other optogenetic systems, which generally use light to induce protein association. 
Wang et al. developed the LOV2 trap and release of protein system (LOVTRAP) where proteins 
of interest were fused to a small protein Zdark (Zdk). Zdk was generated by screening a library 
of amino acid variants of the Z domain from staphylococcal protein A. In the dark state, Zdk 
domain bound to LOV2 with high affinity, which sequestered the fusion protein to LOV2. Upon 
blue light illumination, conformational changes in LOV2 promoted their dissociation to release 
the proteins of interest 65. 
The Aureochrome-1 (AUREO1) transcription factor protein from the alga Vaucheria 
frigida consists of a blue-light-sensing LOV domain in its C-terminal region and a central basic 
region/ leucine zipper (bZIP) domain. Blue light-induced dimerization of monomeric AUREO1 
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increases its affinity for target DNA and enables its functionality in transcriptional control. The 
functionality of AUREO1 as a transcriptional switch was proposed to arise from synergistic 
interactions of its LOV-LOV and bZIP-bZIP domains, which stabilized the monomeric form in 
the dark and the dimeric form in the lit state 66. Blue light-induced dimerization of VfAU1-LOV 
alone, however, is also sufficient to activate fused receptor tyrosine kinases (RTKs) in 
mammalian cells 67. 
The 150-amino-acid vivid (VVD) protein from the filamentous fungus Neurospora 
crassa undergoes homodimerization upon light stimulation. To improve upon its low affinity of 
homodimerization, slow switch-off kinetics, as well as its selectivity, Kawano et al. developed a 
series of oppositely charged VVD pairs referred to as “Magnets”. Charged residues were 
introduced in the VVD homodimerization interface comprising residues 47-56. Similar to the 
attraction between opposite magnetic poles, attraction only occurs between negative-charge-
bearing “n-Magnets” and the positive-charge-bearing “p-Magnets”, but not between n-n or p-p 
Magnet pairs. Magnet dissociation times can be tuned by combining different Magnet mutants 
that have either high affinity or fast dissociation kinetics  68. 
 
Single-chain photodissociable Dronpa (pdDronpa1) 
Zhou et al. developed photodissociable dimeric Dronpa domain, pdDronpa1, which can 
be photoswitched between monomeric and dimeric configurations by cyan and violet light, 
respectively 69.  Compared with its parental tetrameric protein DronpaK145N, pdDronpa1 
utilizes a dimer-to-monomer mechanism to cage/uncage the protein of interest. In addition, 
pdDronpa1 is less likely to aggregate because the dimer has its valency requirement met by its 
own intramolecular interaction. 
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Second-generation tools based on cryptochrome 
Cryptochrome 2 (CRY2) and cryptochrome-interacting basic-helix-loop-helix 1 (CIB1) is 
a heterodimerizing pair that has been widely used in optobiology. The first-generation 
optogenetic tools utilized either full-length CRY2 or its photolyase homology region 
(CRY2PHR; 1-498 a.a.) to interact with CIB1 or its N-terminus (CIBN). The system does not 
require addition of exogenous cofactors, but suffers from a relatively slow dissociation time (t1/2 
≈ 5.5 min) 41. Taslimi et al. sought to generate improved CRY2-CIB1 variants of smaller size, 
altered interaction lifetimes, and reduced dark-state interactions. A truncated version of CRY2 
containing residues 1-535 was identified to possess higher dynamic range and less self-
interaction in the dark compared to CRY2PHR. Truncations in CIB1 revealed that only the first 
81 residues of CIB1, termed CIB81, was functionally at par with CIBN (170 a.a.) in its capacity 
to recruit a cytosolic CRY2PHR to the plasma membrane under blue light. By mutating the 
photocycle-impacting residues in CRY2(535), Taslimi et al. developed two mutants, which had 
shorter (t1/2 ≈ 2.5 min, W349R) and longer (t1/2 ≈ 24 min, L348F) dissociation times 70. In 
addition, a CRY2 mutant (CRY2olig, E490G) with a stronger oligomerizing potential has been 
found by the same group 71. Very recently, Park et al. discovered a short peptide (9 a.a.) which 
significantly enhanced CRY2PHR clustering when appended to its C-terminus 72. When 
compared with other CRY2-based clustering tools, this enhanced reversible clustering tool, 
named "CRY2clust" exhibited lesser concentration dependence for clustering, higher light 
sensitivity, faster assembly and disassembly dynamics, and no undesired accumulation in 
subcellular compartments. Interestingly, the authors report that a 9 a.a. extension of the intrinsic 
PHR domain in CRY2, CRY2[1-507], also increased the efficiency of light-dependent CRY2 
clustering. 
12 
 
Optobiological modules responsive to green light 
Optobiological tools that respond to green light have been largely unavailable. Having 
another excitation wavelength would facilitate multiplexing optobiological applications. 
Kainrath et al. engineered bacterial cobalamin (vitamin B12) binding domains (CBDs) as a green 
light-mediated optobiological tool for use in cultured cells and zebrafish 73. CBD uses a 5’-
deoxyadenosylcobalamin (AdoCbl) cofactor, which absorbs green light. In the dark, CBD forms 
dimers of dimers, which dissociate into monomers under green light irradiation. When fused to 
the intracellular domain of a membrane-anchored murine fibroblast growth factor receptor 
mFGFR-MxCBD and expressed in mammalian cells, the construct induced elevated ERK 
activity, which was then reduced by green light-induced CBD dissociation. Similarly, 
hyperactive FGFR signaling could also be reduced by green light in zebrafish. 
 
Optobiological modules responsive to red and near infrared light 
As we have discussed so far, most optobiological tools are biased towards the blue end of 
the visible spectrum. Blue light, however, is suboptimal for deep tissue penetration. An attractive 
photoactivatable protein is phytochrome, which can be switched between the Pfr (absorbing 
infrared) and Pr (absorbing red light) states using IR and red light. Such a bidirectional control 
makes phytochrome useful in studying processes with fast association and dissociation kinetics. 
While Arabidopsis thaliana phytochrome B (PhyB)-based systems can outshine blue light-
inducible optogenetic systems in vivo due to the better tissue penetrance of red light, such 
systems require the incorporation of an exogenously supplied chromophore, phycocyanobilin 
(PCB), which severely restricts their use 39. Nonetheless, Buckley et al. successfully used this 
system to control subcellular protein localization in zebrafish embryos 74. 
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The recently discovered Rhodopseudomonas palustris bacterial bathy phytochrome, 
BphP1, has optogenetic properties that are similar to plant phytochromes. More attractively, 
BphP1 uses a biliverdin (BV) cofactor that can be produced by mammalian cells. Kaberniuk et 
al.  75 characterized the in vitro and in vivo interactions between BphP1 and its partner protein 
PpsR2 and developed an improved optogenetic system which responds to 740 and 636 nm light. 
This bidirectional control was tapped in a variety of applications ranging from protein 
translocation to gene transcription in cellulo and in vivo. To further improve the functionality and 
dynamic range of the BphP1-PpsR2 pair, Redchuk and colleagues 76 identified a minimal BphP1-
interacting Q-PAS1 fragment (17 kD). Combining this system with blue light-activated AsLOV2 
uncaging, the authors constructed a dual-color optogenetic system called iRIS (near-infrared-
blue-light-inducible shuttle) which exhibited minimal spectral crosstalk. Another homodimerizer 
based on cyanobacterial phytochrome 1 (CPH1) has also been developed 77. This system still 
requires addition of the tetrapyrrole phycocyanobilin (PCB) as a cofactor. 
 
New photo-pharmacological tools 
Photo-pharmacological approaches combine the spatiotemporal precision offered by light 
with the diversity and versatility of chemicals to control cell functions 78-80. The well-established 
rapamycin-mediated dimerization of FKBP- and FRB- fusion proteins has been widely used in 
controlling protein dimerization 81. A light-controllable rapamycin-FKPB-FRB system was 
developed by constructing a photocaged analog of rapamycin 82. Alternatively, Brown et al. 
utilized a photocleavable dimerized rapamycin (dRap) to form inactive FKBP12-dRap-FKBP12 
complexes which could not bind FRB 83. UV light irradiation cleaved dRap into two functional 
Rap molecules and enabled the formation of the FKBP12-Rap-FRB complex. Other UV light-
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mediated dimerizers include caged abscisic acid (ABA) 84, cTMP-Htag 85, a photoactivatable 
crosslinker for SNAPTag and HaloTag 86, and gibberellic acid 87. 
Aside from photocaged small molecules, photocaged amino acids form another critical 
group of photopharmacological reagents 46. Importantly, photocaged unnatural amino acids can 
be incorporated into any protein in response to an amber codon, UAG, through a protocol 
pioneered by Peter G. Schultz 88. To do so, a synthesized pyrrolysyl-tRNA synthetase/tRNA pair 
was optimized to incorporate a photocaged lysine in response to an amber codon in mammalian 
cells. This system has been used to control protein localization 89,  kinase activity 90, gene 
expression 91, and CRISPR/Cas9 activity 92. A similar strategy was used to generate photocaged 
tyrosine, which was incorporated into the Cre recombinase to achieve light-controllable DNA 
recombination 93. Recently, a caged methionine, (S)-N-(4,5-dimethoxy-2-
nitrobenzyloxycarbonyl)-methionine, or NVOC-Met, was synthesized through a low-cost, one-
step reaction 94. UVA (365-nm) light illumination removed NVOC to release methionine. Instead 
of incorporating the photocaged methionine into a protein, the authors used it directly to achieve 
light-mediated repression of gene expression through a pMET17 promoter. 
 
Optobiological control of cellular functions 
Parallel to the development of new photoactivatable proteins, optobiology continues 
finding new applications in the modulation of cellular and organismal functionality though light-
induced uncaging, protein translocation, modulation of concentration and avidity, as well as 
allosteric control (Figure 2). In this section, we summarize recent advances in optobiological 
control of cellular functions. We use subcellular locations (plasma membrane, cytoplasm, and 
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nucleus) to group these cases, highlighting the capacity of light to modulate cellular events with 
high spatial resolution. We also itemize these findings in Table 2. 
 
 
Figure 2. Expanded applications of optobiology in intact cells and multicellular organisms.  
Optobiology has been utilized to control molecular machinery within distinct subcellular 
locations such as the nucleus (Nuc), the cytoplasm (Cyt), the plasma membrane (PM). 
Functionality of protein of interest (POI) can be modulated by light-mediated conformational 
changes in photoactivatable protein (P.P.). 
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Table 2: Emerging cellular and organismal functionality controlled by photoactivatable 
modules. 
Site Function Module Target MOA Organism Ref. 
PM Ca2+ influx  AsLOV2 STIM1 Caging Mammalian and 
hippocampal neurons, 
Drosophila S2 cells, 
transgenic mice 
99 
PM Ca2+ influx  AsLOV2 STIM1 Caging Mammalian cells, 
mice 
100 
PM Ca2+ influx CRY2 STIM1 Association Mammalian cells 
zebrafish embryos, 
mice hippocampi 
101 
PM PI(4,5)P2 
regulation 
CRY2-
CIBN 
Phosphat
ase 
Association Mammalian cells  103 
PM Cell 
contractility, 
PIP2 depletion 
CRY2-
CIBN 
OCRL Association Drosophila embryo 105 
PM Phosphoinositi
de production 
Magnets 
(VVD) 
iSH2, 
Rac1 
Association Mammalian cells  68 
PM Cytoskeletal 
remodeling 
AsLOV2 ITSN, 
Tiam1  
Caging, 
association 
Mammalian cells  63 
PM Membrane 
protrusion 
AsLOV2 GTPase  Caging, 
association 
Mammalian cells  65 
PM Cytokinetic 
furrowing 
LOV-
PDZ 
LARG Association Mammalian cells  110 
PM ERK signaling AsLOV2 SOS Caging, 
association 
Drosophila embryos 118 
PM Differentiation CRY2-
CIBN 
Raf1 Association Mammalian cells, 
Xenopus embryos 
116 
PM GSV 
membrane 
translocation 
CRY2-
CIBN 
PI3K, 
Akt 
Association 3T3-L1 adipocytes 122 
PM RTK signaling CRY2 SH2 of 
PLC𝛾 
Association Mammalian cells, rat 
hippocampal NSCs 
114 
PM Polarity 
signaling 
PIF6-
PhyB 
Pard3 Association Zebrafish embryos 74 
PM Release of 
hormones 
BphS BldD c-di-GMP 
synthesis 
Mammalian cells, 
C57BL/6J mice 
167 
 
PM Insulin 
secretion 
PhotoETP GLP-1R Allosteric 
switch 
Mammalian cells, 
C57BL6 mouse islets 
123 
Cyt Cargo 
transport 
LOV-
PDZ/CRY
2-CIBN 
Motor 
proteins 
Association Mammalian cells, rat 
hippocampal neurons 
129, 
130 
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Table 2 (cont.) 
Site Function Module Target MOA Organism Ref. 
Cyt Peroxisome 
transport 
AsLOV2 PTS Caging Mammalian cells 131 
Cyt Enzymatic 
activity 
AsLOV2 Src, Rac1 Allostery Mammalian cells 133 
Cyt Inhibition of 
JNK and 
p38MAPK 
AsLOV2 Peptides Caging Mammalian cells, 
cerebellar granule 
neurons 
134 
Cyt Inhibition of 
CaMKII 
AsLOV2 Peptides Caging Mammalian cells, 
mice hippocampal 
slices, mice 
135 
Cyt Apoptosis CRY2-
CIBN 
Bax Association Mammalian cells  132 
Cyt Kinase 
activity, 
synaptic 
vesicle 
trafficking 
pdDronpa Kinases  Caging Mammalian cells, C. 
elegans 
69 
Cyt Intracellular 
phase 
transition 
CRY2 IDRs  Clustering Mammalian cells  137 
Cyt Protein trans-
splicing 
AsLOV Intein Caging Mammalian cells  136 
Nuc Transcription CRY2-
CIBN 
Cre  Association Ai9 mice cultured 
neurons  
143 
Nuc Transcription NVOC-
Met 
pMET-
17 
Caging Yeast 94 
Nuc Transcription TAEL  Sox32, 
lefty1, 
Cas9 
Caging, 
association 
Zebrafish embryos 148 
Nuc Transcription CRY2-
CIBN 
dCas9 Association Mammalian cells  145 
Nuc Transcription CRY2-
CIBN 
Il1RN, 
HBG1, 
HBG2, 
ASCL1 
Association Mammalian cells  146 
Nuc Transcription CRY2-
CIB1 
(variants) 
Cre Association Yeast, mammalian 
cells  
70 
Nuc Transcription, 
translocation 
DMNB ABA Caging Mammalian cells  
 
84 
Nuc Transcription, 
behavior  
CRY2-
CIBN 
GCaMP3
.0, 
TRPA1 
Association Drosophila S2 cells, 
Drosophila embryos 
147 
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Table 2 (cont.) 
Site Function Module Target MOA Organism Ref. 
Nuc Epigenetic 
perturbations 
CRY2-
CIB1  
Grm2, 
Histone 
Association Mammalian cells, 
cortical & prefrontal 
cortex neurons 
149 
Nuc Protein 
shuttling, 
transcription 
PIF3-
PHYB 
VP-16/ 
TetR 
Association Mammalian cells, 
zebrafish embryos 
139 
Nuc Nuclear export AsLOV2 CRM1 Caging Mammalian cells  140 
Nuc Genome 
editing 
Magnets Cre  Association Mammalian cells  144 
Nuc Genome 
editing 
Magnets Cas9 Association Mammalian cells  152 
Nuc Genome 
editing 
Caged 
lysine 
Cas9 Caging Mammalian cells 92 
Nuc DNA 
recombination 
dRap Cre Cleavage Mammalian cells  83 
Nuc Histone 
acetylation 
COMET 
probes 
HDAC Isomerization Mammalian cells 150, 
151 
Nuc Histone 
modification 
AsLOV2 Bre1 Caging, 
association 
Yeast  141 
Nuc DNA 
recombination 
Caged a.a Cre Caging Mammalian cells 93 
ABA, abscisic acid; COMET, chemo-optical modulation of epigenetically regulated 
transcription; SOS, Son of Sevenless. 
 
Controlling molecular machinery at the plasma membrane 
Calcium signaling 
Calcium signaling is essential for cellular function and is involved in a variety of cellular 
processes such as exocytosis, excitability, and motility 95. Calcium signaling is also diverse in 
both space and time, requiring precise spatiotemporal control for accurate study 96. 
Optobiological systems have been developed to address this need, but some of the first were not 
specific for calcium 97 and provided modest changes in the intracellular calcium concentration 98, 
which did not reach the physiological range. To produce more robust optobiological tools for 
calcium signaling, Ishii et al. engineered a photocaged fragment of stromal interaction module 1 
(STIM1), the gating factor for the ORAI1 Ca2+ release-activated Ca2+ (CRAC) channel 99. The 
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authors named this system ‘blue light-activated Ca2+ channel switch’, or BACCS. The human or 
Drosophila minimal STIM1 fragment was fused to the C-terminus of AsLOV2, which caused 
steric hindrance in the dark. Blue light-stimulated unfolding of the LOV Jα helix led to the 
exposure of the STIM1 fragment, which allowed it to interact with endogenous or exogenous 
ORAI1 channels to promote reversible extracellular Ca2+ influx within the physiological range. 
The authors demonstrated that the degree of Ca2+ influx was tunable based on the intensity of 
stimulating light, and that the induction could be spatially confined to axon tips and dendrites. 
Using a similar approach, He et al. developed a near-infrared(NIR)-inducible optogenetic system 
(Opto-CRAC) to manipulate Ca2+ influx and Ca2+-dependent gene expression in immune cells to 
promote heightened immune responses and tumor suppression in a melanoma mouse model 100. 
In line with these studies, Kyung et al. engineered OptoSTIM1, a light-inducible system to 
reversibly control Ca2+ influx through endogenous ORAI1 channels 101. By fusing CRY2PHR to 
a truncated form of cytosolic STIM1, the authors used blue light to form OptoSTIM1 clusters, 
which translocated to the plasma membrane to activate ORAI1 channels. More recently, Park et 
al deployed the earlier-described CRY2clust tool in OptoSTIM1 to obtain two-fold faster 
changes in intracellular Ca2+ levels 72. 
 
Modification of phosphoinositides 
Phosphoinositides in the plasma membrane are spatiotemporally regulated and they play 
a key role in the regulation of integral membrane proteins and a variety of cell signaling events 
102. Xie et al. used the CRY2-CIBN protein pair to investigate how membrane depletion of 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) affects the Ca2+-triggered secretion of insulin 
from cultured pancreatic β cells 103. CIBN was anchored to the plasma membrane by a 
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farnesylation motif and CRY2 was fused to a 5’-phosphatase. Blue light illumination induced 
membrane recruitment of the 5’-phosphatase, where it could catalyze the conversion of PI(4,5)P2 
to phosphatidylinositol 4-phosphate (PI(4)P). PI(4,5)P2 depletion reduced Ca2+ influx and 
suppressed insulin secretion, thereby highlighting PI(4,5)P2 as a key regulator of voltage-
dependent Ca2+ channels and Ca2+-triggered insulin secretion from pancreatic β cells. PI(4,5)P2 
is also known to regulate actin polymerization at the plasma membrane 104. Because cell 
contractility depends on cortical actin dynamics, which in turn relies on the plasma membrane 
levels of PI(4,5)P2, membrane depletion of PI(4,5)P2 arrested ventral furrow formation in 
developing drosophila embryos 105. 
Phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P3) is regarded as a secondary 
messenger downstream of phosphatidylinositol 3-kinase (PI3K) that regulates actin 
polymerization and cell polarity 106. Kawano et al. induced spatially confined generation of 
PI(3,4,5)P3 on the plasma membrane of NIH3T3 cells 68. By pairing the Magnet variants 
nMagHigh1 and pMagFast2, where the former was membrane-anchored and the latter cytosolic, 
they used blue light to recruit the pMagFast2-fused, P110 catalytic subunit of PI3K to the plasma 
membrane. Localized lamellipodia protrusion and plasma membrane ruffles occurred on the 
illuminated portion of the cell and membrane retraction occurred on the non-illuminated rear 
side. 
 
Modulation of GTPase activity 
Small Rho GTPases including RhoA, Rac1 and Cdc42 are well known as regulators of 
cytoskeletal dynamics in processes such as cell motility, polarity, cell cycle and many others 
107,108. Therefore, controlling and perturbing their activity with spatiotemporal precision is of 
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great interest and use in biological research. Guntas and colleagues used the iLID system to 
recruit the guanine nucleotide exchange factors (GEFs) ITSN and Tiam1 to user-defined spots on 
the plasma membrane of fibroblasts, allowing control of local GTPase activity in a blue-light 
dependent manner. Membrane recruitment of GEF evoked lamellipodia formation and 
membrane ruffling in a localized fashion 63. Wang et al. used the LOVTRAP system to drive cell 
edge oscillations by mimicking the natural oscillatory pattern of the underlying signaling 
pathways 65. Constitutively active forms of Rac1, RhoA and their upstream GTP exchange factor 
Vav2 were fused to the Zdk protein and sequestered on mitochondria containing LOV2. 
Interestingly, Vav2 activation generated a sustained increase in protrusion and extension 
velocities. 
Successful cell division relies on spatiotemporal precision in the assembly and function 
of the actomyosin-based contractile ring 109. To investigate the spatial and temporal regulation of 
cytokinesis, Wagner and Glotzer developed PR_GEF, a cytosolic tandem PDZ-tagged catalytic 
domain of a RhoA GEF, for the specific activation of RhoA, a membrane-bound GTPase 
functional in contractile ring assembly during cytokinesis 110,111. By anchoring a LOV-caged 
PDZ binding epitope at the plasma membrane, light-induced uncaging of the epitope allowed 
membrane recruitment of PR_GEF and subsequent RhoA activation. When tested in non-
contractile early anaphase cells with a blocked endogenous activating pathway for RhoA, 
PR_GEF successfully induced cytokinetic furrows within the spatially defined illumination 
zones spanning both the cell midzone and the poles, but ingression was incomplete. 
 
22 
 
Modulation of kinase signaling 
Kinase signaling pathways underlie all major cellular processes such as growth, 
proliferation, differentiation, migration, polarization and apoptosis. Achieving precise control 
over the activation of these pathways has been technically challenging. In addition, ligand dose-
response relationship is often non-linear, which is further confounded by adaptive responses as 
well as oscillatory responses 112. Since embryonic development requires inviolable 
spatiotemporal control, perturbing developmental signaling remains a prime challenge. 
Optobiology tackles this challenge by appending photoactivatable proteins to the target and 
rendering it responsive to light, the application of which can be controlled with spatiotemporal 
precision. 
RTKs can activate spatially and temporally distinct signaling networks to mediate 
cellular processes such as cell survival, migration, proliferation, and differentiation 113. To 
bypass ectopic overexpression of receptors, Bugaj et al. developed a light-activated system called 
Clustering Indirectly using Cryptochrome 2, or CLICR, to precisely control endogenous RTK 
signaling in space and time 114. CRY2 was fused to the src homology 2 (SH2) domain of PLCγ, 
an RTK binding domain (BD) that has limited affinity as a monomer. Blue light-induced 
cytosolic clustering of the BD-CRY2s increased their avidity to associate with and consequently 
activate endogenous RTKs. Blue light illumination resulted in successful RTK targeting in 
several cell types expressing the CLICR system. Specifically, the system was found to modulate 
endogenous PDGFRβ, a mediator of fibroblast chemotaxis. 
Our recent work investigated the effect of timed kinase activity on embryonic 
development. Using the CRY2PHR-CIBN system, we activated ERK via membrane recruitment 
of Raf1 in PC12 neuroblasts and in Xenopus embryos. It was known that hyperactive ERK 
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results in the formation of ectopic tail-like structures in developing Xenopus embryos 115. It was 
unclear whether ectopic tail induction was restricted to any specific developmental time window. 
By optically hyperactivating ERK during and post gastrulation, we demonstrated that these 
structures can be induced by hyperactive ERK even after gastrulation 116,117. Johnson et al. used 
the iLID system to probe the importance of the signaling precision of ERK in Drosophila 
embryonic development 118. Blue light-induced uncaging of a plasma membrane anchored iLID 
was used to recruit Son of Sevenless (SOS), a Ras activator, to the membrane, which then 
activated ERK signaling. Two different regions in the embryo exhibited differential sensitivity to 
the same ERK signal – the middle of the embryo was most sensitive and the poles were 
unaffected. Interestingly, hyperactive ERK-induced segmentation defects and subsequent 
lethality occurred only during a brief window of ERK hyperactivation. 
The PI3K signaling pathway is another primary pathway downstream of RTK activation. 
In response to insulin, PI3K signaling regulates the membrane translocation of glucose 
transporter 4 (GLUT4) storage vesicles (GSVs) 119,120. Akt, or protein kinase B, is downstream of 
PI3K activation and is a spatiotemporally-regulated kinase with a variety of intracellular 
substrates that mediate diverse cellular functions 121. To delineate PI3K and Akt’s contributions 
to insulin-regulated GLUT4 trafficking, Xu et al. used the CRY2-CIBN system to recruit either 
the PI3K catalytic domain (Opto-PIP3) or Akt (Opto-Akt) to the plasma membrane 122. In 
adipocytes, compared with insulin stimulation, light-mediated activation of Opto-PIP3 induced a 
comparable magnitude of PIP3 generation, Akt phosphorylation, and GSV membrane 
translocation. Compared to Opto-PIP3, Opto-Akt showed reduced GSV translocation. 
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Allosteric activation of G-protein-coupled receptor 
Allosteric regulation has potential to increase drug specificity as drug discovery is 
presently hampered by the inability to control allosteric sites. The ligand dependent allosteric 
activator 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6- (trifluoromethyl)pyrimidine (BETP) is 
known to modulate activity of glucagon-like peptide-1 receptor (GLP-1R), a class B G-protein-
coupled receptor that is involved in maintenance of glucose levels. Broichhagen et al. 
constructed PhotoETP, a photoswitchable moiety that achieved light-mediated allosteric control 
of GLP-1R 123. Isomerization of photoETP between its trans- and cis- states can be induced by 
blue (440 nm) and UV (330 nm) light. Similar to BETP, trans-PhotoETP potentiates GLP-1R 
through ligand-induced increase of cAMP and Ca2+ levels. This functionality can be switched off 
through UV illumination, which converts trans-PhotoETP to its cis form. 
 
Controlling molecular machinery in the cytoplasm 
Control of organelle and protein trafficking 
Precise positioning of organelles at specific subcellular locations plays a crucial role in 
coordinating signal transduction and cell fate determination, particularly in polarized neuronal 
cells. For instance, mitochondrial positioning near the plasma membrane is crucial to maintain 
Ca2+ influx and T-cell activation 124,125, and specific endosome localization leads to neuron 
polarization and outgrowth 126. Not surprisingly, defective organelle trafficking is involved in 
multiple neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and 
amyotrophic lateral sclerosis 127. A key question is whether defective organelle trafficking is a 
cause or consequence of neurological disorders. Answering this question requires tools that can 
control organelle trafficking in live cells, and recent developments in optobiology provide such 
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tools. Recent work on optogenetic control of cargo trafficking has been reviewed 128. Attaching 
photoactivatable proteins such as LOVpep-PDZ 129 or CRY2PHR-CIBN 130 to motor proteins 
and cargoes allows for the control of organelle trafficking by light. Additionally, light can also 
be used to control protein localization to a specific organelle. For instance, Spiltoir et al fused 
GFP to AsLOV2, which caged a peroxisomal-targeting sequence (PTS) in the dark. Unwinding 
of the ASLOV2 Jα helix under blue light exposed the PTS, which then bound to the Pex5 
peroxisomal import receptor, thereby allowing translocation of the protein to the peroxisome 131. 
In addition, light-induced trafficking of the pro-apoptotic protein Bax to the outer mitochondrial 
membrane was used to initiate apoptosis 132. 
 
Control of enzymatic activity 
Precise spatiotemporal control of enzymatic activity is necessary to better investigate the 
biochemical complexity of living cells. As a recurring theme in optobiology, one method to 
achieve this relies on engineered allosteric control of the target enzyme of interest. Dagliyan et 
al. described a generalizable approach for genetically inserting light-sensitive allosteric switches 
into enzymes to control their activity using light 133. The authors inserted an AsLOV2 as the 
photoswitch into nonconserved surface “tight loops” that were mechanically coupled to the 
active site of a constitutively active Src kinase and the Rac1 GTPase. In the dark, enzyme 
structure and function was unhindered. Upon blue light illumination, a conformational change 
was induced in the LOV2 domain, which was allosterically propagated to the host protein to 
disrupt its structure and function. Interestingly, the photoswitching in each engineered enzyme 
highly resembled the conversion between the natural active and inactive states of the wild-type 
enzymes as revealed by comparison to known crystal structures. 
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Enzymatic activity can be controlled by caging the catalytic domain of the enzyme of 
interest. By inserting a monomeric pdDronpa1 at the N-terminus of the kinase domain and within 
the FG loop, Zhou et al. reported light controllable kinase activity in MEK1, MEK2, and Raf1 69. 
The kinase domain is caged by the dimeric pdDronpa, whereas in the monomeric state it is 
exposed. Thus, kinase activity can be controlled by switching between cyan and violet light. The 
authors discovered a new negative feedback loop in the Raf/MEK/ERK pathway, where ERK 
activation induces phosphatase PP1 or PP2A to dephosphorylate MEK1/2. Using a similar 
strategy, the authors developed a photo-switchable cyclin-dependent kinase 5 (psCDK5), the 
activation of which relocated synaptic vesicles from dendrites to axons in Caenorhabditis 
elegans. 
Enzymatic activity can also be controlled by engineering photocaged peptide inhibitors 
for the enzyme of interest. Melero-Fernandez de Mera et al. caged the C-terminal residues of the 
Jun amino-terminal kinase (JNK) inhibitor JIP1 using AsLOV2 (OptoJNKi) 134. Uncaging of the 
inhibitor peptide under white or blue light enabled it to interact with and inhibit JNK, allowing 
for precise regulation of JNK activity in mammalian cells. Based on molecular dynamic 
simulations of OptoJNKi, the authors proposed adding a terminal phenylalanine residue as a 
simple method for effectively caging certain C-terminal peptides using AsLOV2. Using this 
approach, the authors also generated an inhibitor for p38MAPK, showcasing the method’s 
general applicability to other peptide-based inhibitors. Similarly, Murakoshi et al. developed 
photoactivatable autocamtide inhibitory peptide 2 (paAIP2), an AsLOV2-caged inhibitor for 
endogenous Ca2+/calmodulin kinase II (CaMKII) 135. Activation of paAIP2 during the first 1-2 
minutes of the induction of dendritic long-term potentiation inhibited the process in hippocampal 
slices and amygdalar neurons of mice. 
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Enzyme activity can be regulated by the complementation of its catalytically inactive 
fragments. Wong et al. engineered a photoactivatable protein trans-splicing system that allowed 
light-induced restoration of enzymatic activity 136. A photoactivatable trans-splicing intein 
(LOVInC) was generated by caging one half of the naturally split DnaE intein from Nostoc 
punctiforme using AsLOV2. Light-induced uncaging allowed the split inteins to recombine and 
enable splicing between split enzyme fragments fused to the inteins to reconstitute enzymatic 
activity. This system was applied to activate enzymes including RhoA and the apoptotic protein 
Caspase-7. 
 
Control of phase separation of liquid droplets 
Although many biochemical interactions in cells occur within membrane-bound 
organelles such as mitochondria and the endoplasmic reticulum, they have also been observed in 
a variety of membrane-less organelles. For instance, ribonucleoprotein (RNP) granules are one 
type of membrane-less organelles that harbor RNA-protein interactions. A crucial driving force 
for these interactions is the concentration-dependent association between intrinsically disordered 
protein/regions (IDP/IDRs). RNA-binding proteins often have IDP/IDRs that facilitate their 
condensation into liquid-like droplets within cells. However, understanding of the physiological 
assembly of these granules largely depends on in vitro reconstitution, due to a lack of tools to 
probe protein phase transitions in live cells. Using an optogenetic assay, Shin et al. fused 
CRY2PHR to various sticky IDRs and used blue light to modulate their phase separation 
between liquid and gel-like structures in the cytoplasm of live cells 137. Depending on the 
proximity to the phase boundary, these optoDroplets display distinct assembly kinetics – from 
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fully reversible structures to irreversible aggregates. Thus, optoDroplets facilitate studies of 
physiological assembly and pathological aggregates of liquid droplets in cells. 
 
Controlling molecular machinery in the nucleus 
Control of nucleocytoplasmic protein shuttling 
Protein transfer into and out of the nucleus is critical for the tight regulation of gene 
expression and cell fate 138. Beyer et al. developed a light-inducible system to control the nuclear 
localization of transcription factors in zebrafish 139. By taking advantage of the intrinsic nuclear 
localization signal (NLS) of phytochrome interacting factor 3 (PIF3), synthetic transcription 
factors fused to PHYB with a nuclear export signal (NES) were translocated to the nucleus upon 
illumination with 660 nm light. The transcription factor activity was reversed using 740 nm light, 
leading to PHYB dissociation from PIF3 and nuclear export of the transcription factor. 
To control nuclear export of proteins initially residing in the nucleus, Niopek et al. 
developed a reversible light-inducible nuclear export system, or LEXY, using an AsLOV2-caged 
NES 140. An N-terminal NLS was also introduced into the construct to allow nuclear 
accumulation prior to illumination. In mammalian cell culture, blue light exposure uncaged the 
NES, allowing it to interact with the endogenous nuclear export receptor, CRM1, to mediate 
nuclear export of the construct through nuclear pores. Harnessing this mechanism, the authors 
created a chromatin-anchored LEXY variant through fusion with histone H2B to sequester 
CRM1 and reversibly inhibit endogenous nuclear export. Similarly, Yumerefendi et al. 
introduced a light-inducible nuclear exporter (LINX) by caging a super-PKI-2 NES within the Jα 
helix of AsLOV2 141. NLS sequences with varying strengths were used to direct the proteins to 
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nuclei in the dark. The tools developed by both groups showed rapid export-import kinetics with 
half-lives of seconds to minutes. 
 
Control of gene expression 
The Cre-LoxP system is commonly used to alter gene expression. A split Cre 
recombinase has been used with CRY2-CIBN to control gene expression with high 
spatiotemporal resolution in cell cultures 41, Drosophila 142, and mice 143. This photoactivatable 
split Cre recombinase (PA-Cre 1.0) was constructed by fusing CRY2 and CIBN to the N- and C-
half, respectively. A second-generation PA-Cre (PA-Cre2.0) was generated based on a CRY2 
mutant, L348F, a slow cycler with a dissociation half-life of 24 min 70. Compared with PA-
Cre1.0, PA-Cre2.0 provided a five-fold increase in the dynamic range. Using Magnets, Kawano 
et al. also engineered a light-inducible split Cre recombinase system 144, where an nMag was 
fused to an N-Cre and a pMag was fused to a C-Cre. Because Magnets have slow photocycle 
kinetics (half-life 1.8 h), this split Cre system enabled DNA recombination in cells and in mice 
with a 30 second blue light pulse illumination. 
Achieving simultaneous targeted transcriptional activation of multiple endogenous genes 
to perturb cells has been technically challenging. Two independent groups concurrently 
addressed this challenge by combining the versatility of the CRISPR-Cas9 system with 
optobiology to create similar light-activated CRISPR-Cas9 systems 145,146. In both designs, a 
catalytically inactive dCas9 fused to CIB1/CIBN served as a customizable genomic anchor; a 
fusion containing CRY2PHR and a transactivation (TA) domain (P65/Vp64) was the activator. 
Blue light recruited the freely diffusive activator to the genome anchor, which constitutively 
occupied the promoter region of target genes. Both research groups demonstrated spatially 
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defined gene expression that correlated with the spatial pattern of illumination. Importantly, both 
groups achieved multiplexed photoactivation of genes in cultured cells using multiple sgRNAs to 
target these different genes simultaneously. Also by using the CRY2-CIBN system, Chan et al. 
achieved spatiotemporal control of gene expression in both embryonic and adult Drosophila 
tissues 147. By using two-photon excitation, the authors restricted gene expression to a 20-µm 
region of interest, demonstrating excellent spatial control. 
Transactivation domains commonly used in cultured cells could lead to toxicity when 
applied in certain multicellular organisms such as zebrafish. Reade et al. utilized a more tolerable 
KalTA4 TA domain to develop a light-inducible gene expression system for use in zebrafish 
embryos 148. The authors fused the KalTA4 TA to EL222, a naturally occurring LOV-based 
transcription factor, to create a light-gated transcription factor (TAEL). Using TAEL, a single 2 
min blue light pulse was sufficient to drive light-specific expression, and the system inactivated 
within 30 min after light was turned off. The authors demonstrated spatial control of TAEL by 
generating ectopic endoderm from ectoderm by driving Sox32 expression locally in the 
presumptive ectoderm. They then used TAEL to dissect the distinct roles of nodal signaling in 
early development (mesendoderm specification) and later development (left-right axis 
patterning). 
 
Control of epigenetic states 
Konermann et al. developed a modular two-component optogenetic system to facilitate 
control of gene transcription and epigenetic states in mammalian cells 149. The first component is 
a genomic anchor generated by fusion of a customizable DNA-binding domain to CRY2. The 
second component is an effector domain fused to CIB1.  Blue-light rendered the association of 
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CRY2 and CIB1 and recruited the effector domain to the target region enabling transcriptional 
repression or activation, depending on the nature of the effector. The modular nature of these 
light-inducible transcriptional effectors (LITEs) allows for flexibility in the DNA-binding region 
as well as the effectors thereby enabling a multitude of genomic or epigenetic modifications. 
Epigenetic mark-modifying LITEs (epiLITEs) were developed by including histone effectors in 
LITE to be used for locus-specific histone modification. 
Controlling the subcellular localization of epigenetic modifiers is another powerful way 
to interrogate epigenetic states. The LINXa4 construct discussed earlier was used by 
Yumerefendi et al.  to control a histone modifying E3 ubiquitin ligase Bre1 which 
monoubiquitylates (ub1) the histone H2B in yeast and promotes transcription 141. Fusing an 
NLS-silenced Bre1 to LINXa4 in a BRE1 deletion strain, they demonstrated light-induced 
reversible loss of H2Bub1, which occurred within minutes. The kinetics of the accompanying 
H2Bub1-dependent histone modifications such as tri-methylation of lysine 4 on histone H3 
(H3K4me3) and tri-methylation of lysine 79 on histone H3 (H3K79me3) were monitored, where 
the latter was observed to be much slower than the former, providing mechanistic insights into 
these epigenetic processes. 
Reis et al. developed a method called chemo-optical modulation of epigenetically 
regulated transcription (COMET) to generate a blue light-dependent histone deacetylase 
(HDAC) inhibitor 150,151. The authors amalgamated a fast-relaxing photochromic ligand para-
methyl red (DABCYL) with an ortho-amino anilide (OAA) HDAC inhibitor that targets the 
catalytic zinc in the HDAC active site via electrostatic interactions. Blue light promoted trans-cis 
photoisomerization of DABCYL, which transmitted the electronic alteration to the attached zinc-
chelating anilide for HDAC inhibition. 
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Genome editing 
Attaining spatiotemporal and reversible control over genome editing with minimal cell 
invasiveness is a challenging goal. Nihongaki et al.  used magnets to develop a photoactivatable 
RNA-guided endonuclease Cas9 (paCas9) for applications in CRISPR-mediated genome editing 
152. A split pair of Cas9 (N713, C714) was fused to pMag and nMag, respectively, creating 
paCas9-1. This construct showed no reduction in specificity compared to full-length Cas9 in 
homology dependent repair (HDR) assays, and could cleave endogenous mammalian genomic 
loci with 60% efficiency of that of Cas9. PACas9 could also be used in targeted genome editing 
via HDR when a donor repair template was supplied, with an incorporation frequency of 7.2%. 
Moreover, two additional functionalities were developed using paCas9-1: first, a single point 
mutation D10A converted paCas9-1 from an endonuclease to a nickase, which could reduce off-
target genome modifications by making Cas9 activity dependent on a pair of guide RNAs instead 
of one; second, two point mutations D10A and H840A abolished Cas9 cutting activity, while 
retaining its targeting activity, which could be used to sterically block the transcription of a 
target-gene in an application termed CRISPR interference (CRISPRi) which was also 
demonstrated with luciferase reporters. Similarly, Reade et al. used TAEL to drive Cas9 
expression in zebrafish, which led to tyrosinase gene disruption, demonstrating the CRISPR 
integration of TAEL for gene editing in multicellular organisms 148. 
Using a photopharmacological strategy, Hemphill et al. engineered two Cas9 variants 
with photo-caged lysines at positions K163 and K866, which could be spatiotemporally activated 
with UV light 92. The photo-caged Cas9 variants were completely inactive in the dark and 
achieved wild-type activity with 120 seconds of exposure to 365 nm light. Optical control of 
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CRISPR/Cas9 was used to silence the endogenous trans-membrane transferrin receptor, CD71, 
in HeLa cells. 
 
Challenges and emerging new technologies 
A major challenge in optobiology, both in basic sciences and in clinical research, is light 
delivery. Most photoactivatable proteins respond to visible light. The penetration depth for red 
light in biological tissues is around 0.2-2 mm 153. Furthermore, as the light wavelength decreases, 
its penetration depth is reduced, severely limiting the use of visible light-responsive 
photoactivatable modules in deep tissues. Most in vivo optobiological applications have required 
the insertion of optical fibers to deliver visible light. This approach introduces a two-fold 
challenge: fibers impede free movement of the tethered animal and the insertion procedure may 
cause an inflammatory response in tissues. 
Recent developments in nanotechnology have provided soft, stretchable, and implantable 
microLEDs that allow for wireless optobiology. These devices use miniaturized light-emitting 
diodes (LEDs) that are powered by radio-frequency (RF) scavengers 154-156. To improve the 
chronic biocompatibility and integration with soft neuronal tissues and to use these devices in 
challenging areas such as the spinal cord and peripheral nervous system, fully implantable 
internal devices were made 157. An improved multi-functional device, which included both 
optogenetic and microfluidic channels, allowed for the co-delivery of light and pharmacological 
reagents 158. Organic LEDs have also been designed for high-resolution optogenetics 159 (Figure 
3A). 
Parallel to the development of microLEDs, researchers used upconversion nanoparticles 
(UCNPs) to convert near infrared (NIR) light (800-980 nm) to visible light, which shifted the 
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spectrum of illumination towards the NIR wavelength 160,161. IR light has a higher penetration 
depth (~3-4 mm) than visible light 153. For small animals, such as mice, this penetration depth 
can greatly help light reach deeper brain regions (Figure 3B). However, it remains challenging 
for IR light to penetrate deep brain regions of larger animals including humans. Biocompatible 
UCNPs have been used in photodynamic therapy (PDT) in deep tissues 162. Recent proof-of-
principle work showed that Er/Yb UCNPs coated with IR-sensitive dyes can be used to achieve 
optogenetic stimulation with 980 nm light in cell culture 163,164, C. elegans 165, and mice 100. 
 
 
Figure 3. Emerging technologies for achieving wireless optobiological control in multicellular 
organisms. (A) Wireless optobiology based on radio-frequency powered microLEDs. By 
integrating light source and microfluidic channels, these multiple-functionality devices can light 
up deep tissues in live animals and deliver pharmacological reagents. Reprint with permission 
from 158 (B) Upconversion nanoparticles (UCNPs) convert near infrared light, which has deeper 
penetration depth, to visible light through energy transfer from excited, surface-bound NIR dyes 
to the cores of UCNPs. The output visible light can be used to excite photoactivatable proteins. 
Reprint with permission from 100. 
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Outlook 
Using photoactivatable moieties derived from nature, optobiology utilizes 
photoactivatable molecules in conjunction with proteins of interest to genetically engineer live 
cell systems. Parallel to the emerging field of synthetic biology, optobiology offers attractive 
approaches to customize cell and tissue responses. Orthogonal and multiplexed control of 
signaling circuits would help delineate endogenous signaling mechanisms. Additionally, novel 
functionality can potentially be created by exerting light control over proteins that normally do 
not interact with each other. From a molecular perspective, successful design of an 
optobiological system relies on insights from both molecular modeling and experimentation. 
Although several optobiological modules are available to choose from, benchmarking 
experiments have revealed that tool efficacy varies depending on the cellular context and 
application 64,166. In general, trial and error investigation to identify the appropriate tool is often 
required. Reproducible strategies to insert, remove, modulate, or split modules in target proteins 
call for the development of universal design principles and utilities. 
Beyond the bench, optobiology has also been applied in pre-clinical research using live 
animals. Recent work demonstrated a cell-based therapy that made use of smartphones to induce 
secretion of insulin via an optogenetic approach 167. In this work, optogenetically engineered 
cells that allowed light-triggered release of glucose-lowering hormones were implanted in 
diabetic mice. The implanted cells responded to far-red light, which could be wirelessly 
controlled by a smartphone. Mouse insulin produced in vivo was able to maintain glucose 
homeostasis over several weeks in the diabetic mice. With superior spatiotemporal resolution, 
minimal invasiveness, and reversible operation, optobiological techniques promise to usher in a 
new era of molecular biology and biomedical research. 
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Abbreviations used 
SHH: Sonic Hedgehog; TGFβ: transforming growth factor beta; BMP: bone morphogenetic 
protein; FGF: fibroblast growth factor; ERK: extracellular signal-regulated kinase; BDNF: brain-
derived neurotrophic factor; AsLOV: Avena sativa light-oxygen-voltage; POI: protein of interest; 
TULIPS: tunable light-controlled interacting protein tags; LIDs: light inducible dimers; LOVpep: 
peptide epitope attached to AsLOV2 Jα helix; ePDZ: engineered Erbin PDZ domain; oLID: 
original light inducible dimers; iLID: improved light inducible dimers; LOVTRAP: LOV2 trap 
and release of protein system; Zdk: Zdark; sec: seconds; AUREO1:  Aureochrome-1; bZIP: basic 
region/ leucine zipper domain; RTK: receptor tyrosine kinase; VVD: vivid; pdDronpa1: 
photodissociable dimeric Dronpa; psCDK5: photo-switchable cyclin-dependent kinase 5; CRY2: 
Cryptochrome 2; CIB1: cryptochrome-interacting basic-helix-loop-helix 1; CRY2PHR: CRY2 
photolyase homology region; CIBN: CRY2 N-terminus; TF: transcription factor; PhyB: 
Arabidopsis thaliana phytochrome B; PCB: phycocyanobilin; BphP1: Rhodopseudomonas 
palustris bacterial bathy phytochrome; BV: biliverdin; iRIS: near-infrared-blue-light-inducible 
shuttle; dRap: dimerized rapamycin; ABA: abscisic acid; NVOC-Met: (S)-N-(4,5-dimethoxy-2-
nitrobenzyloxycarbonyl)-methionine; BETP: 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-
(trifluoromethyl)pyrimidine; GLP-1R: glucagon-like peptide-1 receptor; PhotoETP: 
photoswitchable moiety for light-mediated allosteric control of GLP-1R; STIM1: stromal 
interaction module 1; CRAC: Ca2+ release-activated Ca2+; BACCS: blue light-activated Ca2+ 
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channel switch; PI(4,5)P2: phosphatidylinositol 4,5-bisphosphate; PI(4)P: phosphatidylinositol 4-
phosphate; PI(3,4,5)P3: Phosphatidylinositol 3,4,5-trisphosphate; PI3K: phosphatidylinositol 3-
kinase; GEFs: guanine nucleotide exchange factor; prGEF: photo-recruitable GEF; CLICR: 
Clustering Indirectly using Cryptochrome 2; SH2: Src homology domain; BD: binding domain; 
SOS: Son of Sevenless; GLUT4: glucose transporter 4; GSV: GLUT4 storage vesicles; PTS: 
peroxisomal targeting sequence; Jnk: Jun N-terminal kinase; LOVInC: photoactivatable protein 
trans-splicing intein; RNP: ribonucleoprotein; (IDP/IDR): intrinsically disordered 
protein/regions; PIF3: phytochrome interacting factor 3; NLS: nuclear localization signal; NES: 
nuclear export signal; LEXY: light-inducible nuclear export system; LINX: light-inducible 
nuclear exporter; PA-Cre 1.0: photoactivatable split Cre recombinase; TA: transcriptional 
activation; TAEL: TA EL222; LITE: light-inducible transcriptional effectors; epiLITE: 
epigenetic mark-modifying LITE; ub1: monoubiquitin; H3K4me3: tri-methylation of lysine 4 on 
histone H3; H3K9me3: tri-methylation of lysine 79 on histone H3; COMET: chemo-optical 
modulation of epigenetically regulated transcription; HDAC: histone deacetylase; DABCYL: 
fast-relaxing photochromic ligand para-methyl red; OAA: ortho-amino anilide; paCas9: 
photoactivatable Cas9 nuclease; HDR: homology dependent repair; CRISPERi: CRISPER 
interference; LED: light emitting diodes; RF: radio frequency; UCNP: upconversion 
nanoparticles; NIR: near-infrared; IR: infrared; PDT: photodynamic therapy. 
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CHAPTER 2: OPTOGENETIC DELINEATION OF RECEPTOR TYROSINE KINASE 
SUBCIRCUITS IN PC12 CELL DIFFERENTIATION 
This work contains previously published material.* 
 
Abstract 
Nerve growth factor elicits signaling outcomes by interacting with both its high-affinity receptor, 
TrkA, and its low-affinity receptor, p75NTR. Although these two receptors can regulate distinct 
cellular outcomes, they both activate the extracellular-signal-regulated kinase pathway upon 
stimulation with ligand. To delineate TrkA subcircuits in PC12 cell differentiation, we developed 
an optogenetic system where light was used to specifically activate TrkA signaling in the 
absence of nerve growth factor. By using tyrosine mutants of the optogenetic TrkA in 
combination with pathway-specific pharmacological inhibition, we find that Y490 and Y785 
each contribute to PC12 cell differentiation through the extracellular-signal-regulated kinase 
pathway in an additive manner. Optogenetic activation of TrkA eliminates the confounding 
effect of p75NTR and other potential off-target effects of the ligand. This approach can be 
generalized for the mechanistic study of other receptor-mediated signaling pathways. 
 
 
 
 
 
 
                                                 
* Khamo, J.S. et al. (2019). Optogenetic Delineation of Receptor Tyrosine Kinase Subcircuits in PC12 Cell 
Differentiation. Cell Chem Biol 26, 400-410. 
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Introduction 
The dimeric secretory nerve growth factor (NGF), the first discovered neurotrophin, 
exerts a broad spectrum of neuronal functions including cell survival, growth, differentiation 168, 
tissue regeneration 169, pain 170, synaptogenesis, and synaptic plasticity 171. Trophic effects of 
NGF result from its interaction with the high-affinity receptor tropomyosin receptor kinase A or 
TrkA 172. Upon binding to NGF, TrkA undergoes auto-phosphorylation of specific tyrosines in 
its intracellular domain (ICD). Phosphorylated tyrosines in the TrkA ICD serve as docking sites 
for distinct downstream effectors to activate canonical downstream signaling pathways including 
the extracellular-signal-regulated kinase (ERK) and phospholipase C-γ (PLCγ) pathways 173. 
Outcomes of TrkA signaling have been complicated, however, by the discovery that NGF 
also binds to its low-affinity receptor, p75NTR 174. In fact, p75NTR binds to other neurotrophins 
including brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 with similar 
affinities 175. Evidence suggests a two-fold neuronal function of p75NTR: 1) it can functionally 
collaborate with TrkA to enhance neurotrophin binding and receptor activation 176,177, and 2) it 
can also induce cell apoptosis via ProNGF-dependent signaling processes 178. Although NGF 
stimulation leads to ERK phosphorylation primarily through its binding to TrkA, ERK activation 
can also be mediated by p75NTR 179. Thus, the existence of multiple receptors for NGF makes it 
challenging to delineate specific roles of TrkA subcircuits in the biological context 168,180. 
To delineate sole contributions of TrkA and p75NTR to NGF signaling, in vitro and in 
vivo models have been developed. Cell lines and transgenic animal models with either gene 
disrupted have been generated. For instance, the PC12nnr5 cell line expresses only p75NTR 
(lacking TrkA) 181, while PC12-p75- cells express only TrkA (lacking p75NTR) 182. Additionally, 
3T3 cells have been engineered to express TrkA or p75NTR 183. Similarly, p75NTR mutant mice 
40 
 
184 and TrkA knock-out mice 185 have been developed. However, caution should be warranted 
with genetic manipulation for at least two reasons: first, complete deletion of a gene may 
undesirably corrupt its roles in other cellular functions. For instance, p75NTR is widely 
expressed in non-neuronal tissues 186 and is involved in processes such as liver repair 187 and 
muscle regeneration 188. Second, genetic manipulation often causes delayed responses and 
constitutive alteration of gene expression in cells. Alternatively, pharmacological inhibition can 
be used to primarily target specific pathways to dissect the NGF signaling network. However, 
potential off-target effects should be considered 189-191. 
Even at the level of TrkA, contradictory evidence exists with respect to the functionality 
of its downstream subcircuits. Upon phosphorylation, two tyrosine residues, Y490 and Y785, 
serve as primary docking sites for downstream effectors. Y490 associates with Shc and Src 
domains 192, which further activate the Raf/MEK/ERK signaling pathway, whereas Y785 
associates with PLCγ (Figure 4). Work based on a chimeric receptor, a fusion protein of the 
PDGFR extracellular domain (ECD) and TrkA ICD, shows that the mutation of Y785 in TrkA, 
which is believed to primarily activate the PLCγ signaling pathway, does not affect PC12 cell 
differentiation 193. However, overexpression of the Src Homology domains of PLCγ1 inhibits 
NGF-induced PC12 cell differentiation 194, presumably through competition with endogenous 
PLCγ for receptor interaction. This discrepancy can arise from unknown off-target effects of the 
ligand or overexpressed protein domains, both of which are challenging to analyze 
quantitatively. Thus, delineation of TrkA subcircuits calls for the development of new strategies 
that can evaluate the functionality of specific tyrosines of the TrkA ICD with a clean biological 
context free from potential off-targets. 
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The emerging optogenetic techniques provide a new way to study signaling mechanisms 
by integrating photoactivatable proteins with signaling molecules 44,48,195-200. As light can be 
easily manipulated with high spatial and temporal resolution, optogenetic control of signaling 
can provide insights into the kinetic and spatial features of signal transduction. In addition, light 
can bypass ligand-binding to specifically interrogate optogenetically engineered receptors, whose 
ligand can interact with and signal through multiple known and potentially unidentified 
receptors. 
Here, we use an optogenetic approach to specifically elucidate the signaling outcomes of 
TrkA subcircuits in the absence of NGF. By constructing wild-type and tyrosine mutants of the 
optogenetic TrkA receptor, we control canonical TrkA signaling without introducing a ligand-
based chimeric receptor or disturbing the endogenous TrkA expression and function. We find 
that both Y490 and Y785 of TrkA regulate PC12 cell differentiation, with Y490 primarily 
activating the ERK pathway and Y785 contributing to the ERK signaling cascade in a PLCγ- and 
PKC-dependent manner. 
 
Results 
System construction 
Natural signal transduction mediated by TrkA sequentially involves NGF interaction with 
the receptor ECD, receptor dimerization, and a series of autophosphorylation at key tyrosines 
throughout the receptor ICD (Figure 4A). Several tyrosines located within the receptor kinase 
domain are critical for optimal kinase activity, and some tyrosines located outside of the kinase 
domain serve as docking sites for initiating factors of intracellular signaling pathways. To bypass 
the ligand requirement for receptor activity, we constructed an optogenetic TrkA (Lyn-
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TrkAICD-AuLOV-GFP) by fusing a homo-associating domain, the light-oxygen-voltage domain 
of aureochrome1 from V. frigida (AuLOV) 67, to the ICD of the wild-type TrkA receptor (Figure 
4B). This construct will be referred to as “WT ICD.” Lyn is the lipidation motif of the Src family 
Lyn kinase, which serves as a membrane-targeting peptide that replaces the transmembrane and 
extracellular domain of TrkA. This construct is different from a previously reported optogenetic 
TrkA system, which used the full-length TrkA fused to the photoactivatable protein, 
cryptochrome 2 201. We chose to control TrkA ICD alone to avoid the potential interaction of 
TrkA ECD with other receptors such as p75NTR 202, although this interaction is a subject of 
debate 203. For practical convenience, we chose AuLOV because of its smaller size (145 a.a.) 
compared to cryptochrome 2 (498 a.a.). In our system, we expected that light-induced homo-
association of AuLOV would bring TrkA kinase domains within proximity of each other to 
initiate the cross- and autophosphorylation of specific tyrosines throughout the ICDs, including 
Y490 and Y785. To delineate the signaling outcomes of these two docking sites, we also 
constructed single tyrosine-to-phenylalanine mutants (Y490F, Y785F) and a double mutant 
(Y490/785F) of WT ICD. Note that light-induced activation of the optogenetic TrkA system 
should not activate the endogenous wild-type TrkA. 
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Figure 4. Design of the optogenetic TrkA system. (A) Representation of the wild-type TrkA 
receptor. TrkA is a Type I transmembrane protein anchored at the plasma membrane by a single-
helix transmembrane domain (TM). Nerve growth factor (NGF) associates with the extracellular 
domain (ECD) to promote receptor dimerization and phosphorylation of key tyrosines within the 
intracellular domain (ICD). Y670, Y674, and Y675 are critical for kinase activity, while Y490 
and Y785 are involved in the initiation of the Raf/MEK/ERK and PLC𝛾-PKC signaling 
pathways, respectively. (B) Schematic representation of the optogenetic TrkA receptor. The ECD 
and TM are replaced by a lipidation motif to abolish ligand sensitivity, while retaining normal 
orientation and localization at the plasma membrane. Light sensitivity is introduced through 
fusion with the photosensitive protein, AuLOV. Illumination with blue light should promote 
dimerization of receptor ICDs and activation of downstream signaling pathways. Green 
fluorescent protein (GFP) serves as a probe for system expression. 
 
Blue light illumination induces homo-association of optogenetic TrkA in live cells 
When overexpressed in PC12 cells, WT ICD and its mutant variants localized primarily 
on the plasma membrane (Figure 5A). Compared to a cytosolic GFP, optogenetic TrkA variants 
showed a higher fluorescence intensity at the plasma membrane relative to the cytoplasm (Figure 
5B). In the absence of ligand binding, the plasma membrane is the main subcellular localization 
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of wild-type TrkA in PC12 cells, which was revealed in previous work by crosslinking NGF with 
wild-type TrkA 204 as well as immunostaining of TrkA 205. In addition, overexpression of 
fluorescently labeled TrkA results in primary targeting to the plasma membrane 206,207. Here, we 
reproduced the results of TrkA overexpression and found that TrkA-mCherry overlapped with 
WT ICD in PC12 cells (Figure 5C), suggesting that the Lyn sequence allows for subcellular 
localization of TrkA ICD to the natural membrane compartment of full-length TrkA. 
To confirm that blue light could induce the homo-association of WT ICD, we performed 
a bimolecular fluorescence complementation (BiFC) assay based on split Venus fragments, VN 
(amino acid 1-154) and VC (amino acids 155-238) 208,209. Two plasmids were constructed: Lyn-
TrkAICD-AuLOV-VN and Lyn-TrkAICD-AuLOV-VC. As expected, after 20 minutes of blue 
light illumination, fluorescence intensity from cells co-transfected with both plasmids increased 
(Figure 5 D-E). In cells co-transfected with the No AuLOV control (Lyn-TrkAICD-VN and Lyn-
TrkAICD-VC), the same dose of blue light did not increase the fluorescence intensity (Figure 5 
F-G). 
We also used structured illumination microscopy (SIM) to probe blue-light-induced 
receptor homo-association. MDA-MB-231 cells were transfected with WT ICD and were 
exposed to blue light. To quantify the light-induced homo-association of WT ICD, we analyzed 
the SIM images using the thresholding technique. By setting the threshold at the midpoint value 
between the minimal and maximal  intensity of the background-subtracted cell images, we 
calculated the percentage of above-threshold regions over the whole cell area using ImageJ based 
on a published protocol 210. Following 5 minutes of blue light (405 nm) illumination, the above-
threshold percentage increased in cells transfected with WT ICD, in stark contrast to cells 
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transfected with the No AuLOV control (Lyn-TrkAICD-GFP), which showed no increase in the 
above-threshold percentage (Figure 5 H-I). 
 
 
Figure 5. Optogenetic TrkA localizes to the plasma membrane and homo-associates in 
response to blue light. (A) Fluorescence microscopy images of PC12 cells expressing a cytosolic 
GFP or variants of the optogenetic TrkA system. (B) Red-line profile analysis of fluorescence 
images in (A) reveals a strong membrane localization of the optogenetic constructs. (C) 
Overexpression of WT ICD and TrkA-mCherry shows that both fusion proteins primarily 
localize to the plasma membrane. (D) Bimolecular fluorescence complementation assay based on 
split Venus fragments. A 20-minute blue light illumination (5 mW/cm2) increased the         
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Figure 5 (cont.) fluorescence intensity in cells co-transfected with Lyn-TrkAICD-AuLOV-VN 
and Lyn-TrkAICD-AuLOV-VC. Images of the same cells were acquired before and after blue 
light treatment. (E) Intensity quantification along four dash-line profiles outlined in (D). (F-G) 
Same as (D-E) except that a No AuLOV control, Lyn-TrkAICD-VN and Lyn-TrkAICD-VC, is 
used. The same blue light illumination does not enhance the fluorescence intensity. Data shown 
in (D-G) are for representative cells of more than 500 cells (N>500) from two biological 
replicates (n=2). (H) Structured illumination microscopy (SIM) images of MDA-MB-231 cells 
expressing WT ICD (top panels) or No AuLOV control (bottom panels) before and after blue 
light (405 nm) irradiation. (I) Quantification of the fraction of images whose intensity is above a 
threshold set at 50% of the maximum intensity of the background-subtracted images. Data shown 
in (H-I) represent WT ICD (N=4) and No AuLOV (N=3) from two biological replicates (n=2). 
Scale bar = 10 μm. 
 
In addition to microscopy, we were inspired by a previous optogenetic study 211 to use 
native PAGE to resolve the light response of AuLOV. Cells were transfected with WT ICD and 
lysates were harvested in 0.5% Triton X-100 in PBS. Lysates were treated with blue light (5 
mW/cm2) for 5 minutes or kept in the dark. Equal amounts of each lysate were loaded on a 
native gel. The lane containing the illuminated sample underwent continued exposure to blue 
light throughout the electrophoresis. Samples were then analyzed by western blot using an anti-
GFP antibody. As expected, blue light resulted in a reduced-mobility shift of the most prominent 
band in the dark control, indicative of light-mediated homo-association (Figure 6). 
 
 
Figure 6. Native PAGE mobility shift assay shows that blue light induces homo-association of 
WT ICD. The most prominent band in the dark control (left arrow) was depleted in the light 
sample, which coincided with an enrichment of a low mobility band (right arrow). This figure 
shows the result of one experiment (n=1). 
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Light-induced activation of optogenetic TrkA results in PC12 cell differentiation 
PC12 cells project neurites in response to NGF stimulation, a process referred to as 
differentiation (Figure 7A). We proceeded to determine whether WT ICD activation could 
achieve a similar cellular outcome. PC12 cells transfected with WT ICD were exposed to blue 
light (300 µW/cm2) for two days in a humidified 37 °C CO2 incubator before their fluorescence 
images were acquired. Light stimulation of these cells resulted in significant differentiation 
(45%) compared to cells kept in the dark (12%) (Figure 7B). Cells expressing the optogenetic 
construct without the TrkA ICD (No ICD) showed little differentiation in both light and dark 
(<5%), indicating that light-induced differentiation was ICD-dependent. Cells expressing No 
ICD showed robust differentiation (>68%) when treated with 50 ng/mL NGF, indicating that 
endogenous TrkA retained ligand sensitivity and signaling activity. 
 
Light-induced activation of optogenetic TrkA mutants results in diminished PC12 cell 
differentiation 
To determine the functional role of Y490 and Y785 in differentiation, we transfected 
PC12 cells with mutant constructs and illuminated for 24 hours as previously described. Cells 
expressing Y490F or Y785F exhibited significantly reduced levels of light-induced 
differentiation (18% or 15%, respectively) compared to cells expressing WT ICD (36%) (Figure 
7 C-D). Furthermore, the degree of differentiation undergone by cells expressing Y490/785F 
(6%) was similar to that displayed by cells expressing No ICD (4%), suggesting that Y490 and 
Y785 each contributed to TrkA-mediated PC12 cell differentiation. 
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Figure 7. Optogenetic TrkA promotes PC12 cell differentiation in response to blue-light 
stimulation. (A) Image for reference depicting differentiated (yellow box) and undifferentiated 
(red box) PC12 cells transfected with No ICD and treated with 50 ng/mL NGF for 24 hours. (B) 
Differentiation ratios calculated for PC12 cells expressing WT ICD or No ICD. Transfected cells 
were illuminated with 300 μW/cm2 blue light or kept in the dark for 44 hours prior to imaging. 
WT ICD mediated significant light-induced differentiation compared to No ICD. Cells 
expressing No ICD in the presence of 50 ng/mL NGF underwent robust differentiation in a light-
independent manner. Values represent the mean ± standard deviation of three biological 
replicates (n=3) with >70 cells counted per replicate. (C) Differentiation ratios calculated for 
PC12 cells expressing variants of the optogenetic TrkA system. Transfected cells were 
illuminated with 300 μW/cm2 blue light for 24 hours prior to imaging. Y490F and Y785F   
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Figure 7 (cont.) showed a significant reduction in light-induced differentiation compared to WT 
ICD. Y490/785F resulted in a differentiation ratio similar to that of No ICD. Values represent the 
mean ± standard deviation of two biological replicates (n=2) with >900 cells counted per 
replicate. (D) Representative fluorescence images of the conditions reported in (C). Scale bar = 
50 µm. 
 
Light-induced optogenetic TrkA mutants differentially activate the ERK and PLCγ pathways 
To interrogate the mechanism behind the reduced differentiation mediated by the 
optogenetic TrkA mutants, we performed western blots to probe the activity of downstream 
signaling pathways. To minimize baseline signaling activity and capture subtle differences 
between conditions, PC12 cells were transfected with mixtures of the variant ICD constructs and 
the No ICD construct. Cells were illuminated for 10 minutes with 5 mW/cm2 blue light prior to 
lysis. Both Y490F and Y785F showed a significant reduction in ERK signaling compared to WT 
ICD, with the reduction for Y490F being more pronounced (Figure 8A, Lanes 4, 6, and 8). Cells 
expressing Y490F showed no change in light-induced PLC𝛾 activity compared to WT ICD, 
while Y785F showed a complete loss of PLC𝛾 activity (Figure 8B, Lanes 4, 6, and 8). These 
results indicate that Y490 primarily contributed to ERK activity, while Y785 primarily 
contributed to PLC𝛾 activity. Additionally, Y785 seemed to partially contribute to ERK 
signaling as evidenced by the residual ERK activity observed for Y490F (Figure 8A, Lane 6) and 
the reduction in ERK activity observed for Y785F (Figure 8A, Lane 8) compared to WT ICD. To 
confirm that the observed variations in signaling were a result of specific mutations and not due 
to significant variability in system expression, lysates were probed with an anti-GFP antibody. 
All constructs were expressed at a comparable level (Figure 8C). 
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Figure 8. Light-induced optogenetic TrkA mutants differentially activate the ERK and PLCγ 
pathways. Western blot analysis of light-induced (A) ERK and (B) PLC𝛾 activity exhibited by 
PC12 cells expressing variants of the optogenetic TrkA system. Transfected cells were serum-
starved overnight following transfection, and were illuminated with 5 mW/cm2 blue light or kept 
in the dark for 10 minutes prior to lysis. Compared to WT ICD, Y490F displayed a dramatic 
reduction in ERK activity with no change in PLC𝛾 activity. Y785F showed a relatively modest 
reduction in ERK activity with nearly abrogated PLC𝛾 activity. Y490/785F showed no light-
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Figure 8 (cont.) induced activity for either pathway, similar to No ICD. Values represent the 
mean ± standard deviation of three separate experiments (n=3) for ERK and two separate 
experiments (n=2) for PLC𝛾. (C) Western blot analysis of system expression by probing GFP. 
Expression level across samples fluctuates within 16%. 
 
Y785 contributes to ERK signaling and PC12 cell differentiation in a PLC𝛾-PKC dependent 
manner 
Given that Y785 is essential for PLC𝛾 activity, we speculated that the contribution of 
Y785 to ERK signaling was mediated by pathway crosstalk. Indeed, findings from previous 
studies support this notion 212,213. To validate this, we transfected PC12 cells as previously 
described with a combination of Y490F and No ICD. Transfected cells were then treated with a 
PLC𝛾 inhibitor (U73122, 1 μM) or a PKC inhibitor (GF 109203X, 1 μM) 10 minutes prior to 
illumination. With the inhibitors still present, cells were then illuminated for 10 minutes with 5 
mW/cm2 blue light before lysis and subsequent immunoblotting (Figure 9A). Compared to 
untreated cultures, all cells treated with inhibitors displayed an abrogation of the light-induced 
residual ERK activity mediated by Y490F (Figure 9A, Lanes 2, 4, and 6), suggesting that the role 
of Y785 in ERK signaling is dependent on the PLC𝛾-PKC pathway. To confirm that the 
observed variations in signaling were not due to significant variability in system expression, 
lysates were probed with an anti-GFP antibody. All constructs were expressed at a comparable 
level (Figure 9B). In addition to interrogating the short-term effect of inhibitors on light-induced 
ERK signaling mediated by Y490F, we set out to determine the effect of long-term inhibition on 
PC12 cell differentiation. PC12 cells overexpressing Y490F were illuminated with blue light 
(300 µW/cm2) for 24 hours in the presence or absence of U73122 (1 μM) or GF 109203X (1 
μM). Inhibitors were added 1 hour prior to illumination. Cell cultures treated with either inhibitor 
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showed significantly reduced differentiation, suggesting that Y785 also contributes to PC12 cell 
differentiation in a PLCγ-PKC dependent manner (Figure 9 C-D). 
 
 
Figure 9. Y490F-mediated ERK signaling is abolished by PLCγ-PKC inhibitors. (A)  Western 
blot analysis of light-induced ERK activity exhibited by PC12 cells expressing Y490F. 
Transfected cells were serum-starved overnight following transfection and were treated with a 
PLC𝛾 inhibitor (U73122, 1 μM) or a PKC inhibitor (GF 109203X, 1 μM) for 10 minutes prior to 
illumination. Cells were subsequently illuminated with 5 mW/cm2 blue light or kept in the dark 
for 10 minutes prior to lysis. Cells treated with U73122 or GF 109203X had abolished light-
induced ERK activity compared to the untreated control. Values represent the mean ± standard 
deviation of two separate experiments (n=2) for untreated, and four separate experiments (n=4) 
for U73122 and GF 109203X. (B) Western blot analysis of system expression by probing GFP. 
Expression level for illuminated conditions fluctuates within 14%. (C) Differentiation ratios 
calculated for PC12 cells expressing Y490F in the presence of U73122 (1 μM) or GF 109203X 
(1 μM). Inhibitors were added to cells 1 hour prior to illumination. Cells were illuminated with 
300 μW/cm2 blue light for 24 hours prior to imaging. Cells treated with U73122 or GF 109203X 
had decreased light-induced differentiation compared to the untreated control, which received 
inhibitor vehicle (DMSO). Values represent the mean ± standard deviation of three biological 
replicates (n=3) with >40 cells counted per replicate (D) Representative fluorescence images of 
the conditions reported in (C). Scale bar = 50 µm. 
 
53 
 
Discussion 
We developed an optogenetic TrkA system to study differentiation in PC12 cells by 
photo-activation of the TrkA ICD and its downstream signaling pathways. Light-mediated homo-
association of TrkA resulted in elevated ERK and PLC𝛾 activity. Light stimulation specifically 
activated the optogenetic TrkA, efficiently decoupling its signaling from endogenous TrkA and 
p75NTR. By generating mutants of the signal pathway-specific tyrosines, Y490 and Y785, we 
used this system to determine the mechanisms by which TrkA regulates PC12 cell 
differentiation. In a previous study, we demonstrated that optogenetic activation of 
Raf/MEK/ERK signaling is sufficient to induce PC12 cell differentiation, suggesting that this 
pathway is a strong correlating factor for the phenotype 116. From our experiments employing 
optogenetic TrkA mutants in combination with pathway-specific inhibitors, we propose a model 
of the TrkA signaling network in the context of PC12 cell differentiation (Figure 10). We find 
that Y490 regulates ERK signaling and Y785 primarily regulates PLC𝛾 signaling. Y785 also 
promotes ERK signaling in a PLC𝛾-PKC-dependent manner. Indeed, previous studies showed 
that PKC could feed into the Raf/MEK/ERK signaling cascade 212,213. The reduced 
differentiation caused by the Y490F and Y785F single mutants, and the abolished differentiation 
observed for the Y490/785F double mutant, suggest that TrkA uses both Y490 and Y785 to 
activate Raf/MEK/ERK signaling to promote PC12 cell differentiation. 
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Figure 10. Proposed model for the role of Y490 and Y785 in TrkA-mediated PC12 cell 
differentiation. The Raf/MEK/ERK signaling cascade, primarily instigated by Y490 of TrkA, is 
essential for PC12 cell differentiation. Y785 instigates the PLC𝛾-PKC pathway, which feeds into 
the Raf/MEK/ERK signaling cascade. Mutating Y785 or inhibiting the PLC𝛾-PKC pathway 
results in diminished receptor-mediated ERK signaling and differentiation in PC12 cells. 
 
Based on previous studies 192,193, PC12 cells expressing the Y490/785F double mutant did 
not differentiate in the presence of NGF, in agreement with our optogenetic result. However, the 
individual contribution of Y490 and Y785 to PC12 cell differentiation has been elusive. In one 
case, expression of single mutants Y490F and Y785F did not affect NGF-induced PC12 cell 
differentiation, suggesting a redundancy in their phenotypical role 192. In the other case, Y490F 
resulted in a dramatic loss of differentiation while Y785F had no effect 193. This discrepancy may 
be due to the nature of the ligands (i.e., NGF versus PDGF) used in these studies. 
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Using our optogenetic TrkA system, we show that Y490 and Y785 make significant and 
additive contributions to PC12 cell differentiation. We found that Y490F and Y785F each 
diminished PC12 cell differentiation to approximately half of that promoted by WT ICD (Figure 
7C). A similar additive trend was observed for their capacity to activate ERK (Figure 8A). 
Stephens and colleagues 192 observed a similar reduction of ERK activity for both Y490F and 
Y785F compared to wild-type TrkA. At the phenotypic level, however, Y490F and Y785F 
promoted a degree of PC12 cell differentiation comparable to that promoted by wild-type TrkA. 
These results indicate that an ERK signaling threshold exists for establishing maximal 
differentiation. It is possible that this threshold was exceeded by both Y490F and Y785F when 
stimulated with NGF. Here, we note that PC12 cell differentiation mediated by WT ICD was less 
than that of NGF treatment (Figure 7B). We speculated that this was a result of a difference in 
signaling intensity between ligand- and light-simulated receptors. To test this idea, we compared 
the ERK activity induced by WT ICD (Figure 11A) to NGF treatment (Figure 11B). Given that 
not all cells are light-responsive in transfected cultures, we defined the signaling response of 
optogenetic TrkA as . We defined the NGF signaling 
response of untransfected cells as . R is the signal ratio of phosphorylated ERK 
over total ERK probed by western blot. Figure 7 A-B shows that light elicited a milder signaling 
response (  compared to NGF treatment ( . This result suggests that 
NGF elicits higher ERK activity than WT ICD, at least on a short time scale (5-10 minutes). To 
determine if a similar signaling difference exists at a longer time scale, we compared the ERK 
activity generated by NGF and light-activated WT ICD after 4 hours and 24 hours of treatment. 
As expected, NGF promoted higher ERK activity than WT ICD at both time points (Figure 11C). 
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Figure 11. NGF elicits higher ERK activity compared to optogenetic TrkA and NGF-mediated 
PC12 cell differentiation is reduced by pharmacological inhibition of PLCγ and PKC in a 
dose-dependent manner. (A) Western blot analysis of two separate experiments. Transfected 
cells (No ICD and WT ICD) were serum-starved overnight following transfection. Cells were 
illuminated with 5 mW/cm2 blue light or kept in the dark for 10 minutes prior to lysis. (B) 
Untransfected cells were serum-starved overnight prior to treatment. Cells were untreated or 
treated with NGF (100 ng/mL) for 5 minutes prior to lysis. The ERK activity mediated by 
optogenetic TrkA was lower than that of NGF. (C) Western blot analysis of ERK signaling 
mediated by long-term NGF or WT ICD activity. PC12 cells were transfected with WT ICD and 
serum-starved overnight following transfection. Cells were then kept in the dark, illuminated 
with 300 μW/cm2 blue light, or treated with NGF (50 ng/mL) for 4 or 24 hours prior to lysis. 
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Figure 11 (cont.) Untreated cells received NGF vehicle (sodium acetate). NGF stimulation 
elicited higher ERK activity than WT ICD for both durations. All samples are normalized to 
Lane 1. (D) Differentiation ratios for PC12 cells treated with NGF in the presence of U73122 or 
GF 109203X. Serum-starved cells were treated with inhibitors (1, 5, 7.5, 10, and 20 μM) 1 hour 
prior to NGF treatment. Cells were treated with NGF (50 ng/mL) for 24 hours. Cells were 
stained with 1 µM Calcein AM 10 minutes before imaging. NGF-induced PC12 cell 
differentiation was reduced by U73122 or GF 109203X in a dose-dependent manner. Untreated 
cells received NGF vehicle (sodium acetate) and inhibitor vehicle (DMSO). Values represent the 
mean ± standard deviation of two biological replicates (n=2) with >400 cells counted per 
replicate. 
 
Thus, the previously observed reduction of ERK activity for NGF-treated PC12 cells 
expressing either Y490F or Y785F may still surpass the signaling threshold required for 
saturated differentiation, thereby obscuring the contribution of individual tyrosines 192. On the 
other hand, the optogenetic Y490F and Y785F likely produce a sub-threshold ERK activity when 
stimulated with light, providing advantages in interpreting the phenotypic role of each tyrosine. 
These results suggest that the difference between light- and ligand-induced PC12 cell 
differentiation resulted from their distinct potency in the induction of ERK signaling, the reason 
for which has yet to be determined, although it can be speculated that p75NTR plays a role in the 
presence of the ligand. In the physiological context, while Y490 primarily mediates the ERK-
dependent trophic effects of NGF, we speculate that the role of Y785 in ERK signaling becomes 
more critical where NGF concentrations are low. 
Finally, we asked if pharmacological inhibition of NGF-induced PLCγ-PKC activity 
would support our proposed model of the TrkA signaling network in the context of PC12 cell 
differentiation. We performed a differentiation assay in the presence of U73122 or GF 109203X. 
As expected, NGF-induced differentiation was reduced by both inhibitors in a dose-dependent 
manner, supporting our previous finding that the PLCγ-PKC axis contributes to PC12 cell 
differentiation (Figure 11D). 
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Optogenetic activation of TrkA provides an attractive approach to dissect NGF signaling 
processes by leaving the endogenous TrkA expression unperturbed and by bypassing p75NTR 
signaling. As we have demonstrated, optogenetics can also be applied together with conventional 
inhibitor-based assays to further delineate signaling mechanisms. Although this work has 
primarily focused on delineation of TrkA signaling in mammalian cells, utilization of this 
optogenetic TrkA system in multicellular organisms should be applicable. Indeed, recent work 
from multiple laboratories including our own has demonstrated optogenetic control of 
intracellular signaling pathways in drosophila 105,118, zebrafish 74,148, Xenopus 116, and mice 
101,149,214,215. Notably, in vivo application of optogenetics has been significantly improved by the 
utilization of novel nanometer materials, such as upconversion nanoparticles 100,160,161,216, to 
convert near-infrared light to visible light and facilitate deep-tissue light delivery. As receptor 
tyrosine kinase activation is a common function for a variety of growth factors and cytokines, we 
expect that this strategy can be generalized to study other receptor-mediated signal transduction 
pathways. 
 
Significance 
Cell fate is largely determined by integrating and processing a variety of signaling inputs 
from the environment. To effectively and precisely transmit extracellular signals into the cell, 
delicate signaling machinery is required. Transmembrane receptors serve as the major machinery 
for transducing membrane-impermeant extracellular signals. In some cases, one type of ligand 
may bind to a variety of receptors to elicit distinct signaling outcomes. The signaling 
mechanisms of these receptors are often confounded particularly where common downstream 
signaling pathways are activated. In these cases, mechanistic delineation of the signaling 
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mediated by each type of receptor calls for a strategy that can successfully decouple receptor 
activity. Nerve growth factor is one such ligand that interacts with both its high-affinity and low-
affinity receptors, TrkA and p75NTR, both of which activate the extracellular-signal-regulated 
kinase pathway. To delineate TrkA subcircuits from those of p75NTR, we developed an 
optogenetic system where light was used to specifically activate TrkA signaling in the absence of 
nerve growth factor. By combining optogenetics with pharmacological assays, we demonstrated 
that the tyrosine residues Y490 and Y785 of the TrkA intracellular domain each contributes to 
PC12 cell differentiation through the extracellular-signal-regulated kinase pathway in an additive 
manner. Because receptor tyrosine kinase signaling is involved in neurological disorders, 
development, and cancer, we believe that delineating the signaling outcomes of TrkA subcircuits 
could lead to new insights into pathological conditions. 
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CHAPTER 3: SINGLE-MOLECULE ANALYSIS OF FLUORESCENT CARBON DOTS 
BY TIRF MICROSCOPY 
This work contains previously published material*† 
 
Abstract 
Carbon dots are an attractive nanomaterial in cell and molecular biology because of their 
biocompatibility and luminescence properties. To guide particle development for use in varying 
biological assays, an understanding of particle photophysics is required. Although bulk-state 
measurements provide some insight on particle behavior, single-molecule analysis proves useful 
in precisely characterizing the photophysical properties of carbon dots. Here, we report the 
single-molecule analysis of carbon dots by total internal reflection fluorescence microscopy. This 
work was performed in collaboration with the laboratory of Dr. Dipanjan Pan in the Department 
of Bioengineering at the University of Illinois at Urbana-Champaign. The Pan Laboratory 
synthesized and provided the carbon dots. 
 
 
 
 
 
 
                                                 
* Misra, S.K., Srivastava, I., Khamo, J.S., Krishnamurthy, V.V., Sar, D., Schwartz-Duval, A.S., Soares, J.A.N.T., 
Zhang, K., and Pan, D.P.J. (2018). Carbon dots with induced surface oxidation permits imaging at single-particle 
level for intracellular studies. Nanoscale 10, 18510-18519. 
† Fathi, P., Khamo, J.S., Huang, X., Srivastava, I., Esch, M.B., Zhang, K., and Pan, D.P.J. (2019). Bulk-state and 
single-particle imaging are central to understanding carbon dot photophysics and elucidating the effects of precursor 
composition and reaction temperature. Carbon 145, 572-585. 
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The analysis of carbon dots synthesized in the presence of N-methyl morpholine-N-oxide 
 In this work, mutli-color carbon dots (CDs) were synthesized using sucrose as the carbon 
source in the presence of N-methyl morpholine-N-oxide (NMMO). NMMO is a mild oxidant 
that mediates the nanoscale surface oxidation of CDs to enhance particle brightness and trigger 
luminescence tuning (Figure 12). Resulting CDs were fractionated by emission wavelength using 
chromatographic separation. Four fractions were isolated: blue (CD-NMMO-B), green (CD-
NMMO-G), yellow (CD-NMMO-Y), and red (CD-NMMO-R). To compliment the bulk-state 
measurements performed by the Pan Lab, we analyzed these CDs at the single-molecule level by 
using total internal reflection fluorescence (TIRF) microscopy. 
 
 
Figure 12. Separated fractions of carbon dots having induced surface oxidation allows imaging 
at single-particle level and can be used for intracellular studies. 
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For single-particle imaging, we deposited 40 µL of solutions containing CDs or CD-
NMMOs to each cavity (1 mm in diameter) of a polydimethylsiloxane (PDMS) chamber (Figure 
13A). Such a device allows for detection of multiple types of particles on the same substrate. The 
sample was diluted in water so that 500 particles were detected within an 80 µm × 80 µm field of 
view. A home-built TIRF microscope equipped with a 488 nm, a 100× oil-immersion objective, 
and an electron multiplying Charge-Coupled Device (EMCCD) was used to image individual 
particles. Individual particles were detected as bright diffraction-limited spots (Figure 13B). The 
excitation power was 1.5 mW at the back aperture of the objective. Similar images were obtained 
from CD-NMMO-B (Figure 13C), CD-NMMO-Y (Figure 13D), CD-NMMO-G (Figure 13E) 
and CD-NMMO-R (Figure 13F) samples. The excitation power was 1.5 mW at the back aperture 
of the objective. A control with solvent (water) alone was measured to confirm that the signal 
was indeed resulting from the CDs. As shown in the Figure 13G, there are significantly less, if 
any, particles that can be detected for this negative control. Ten time-stamped images of 600 
frames were then taken for each field of view. With a dynamic frame transfer mode turned on, 
transfer time between sequential frames is about 1 ms, which makes the total trajectory time 
slightly longer than 60 sec with a 100 ms exposure time. 
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Figure 13. Single particle imaging of CD-NMMO and its fractions CD-NMMO-B, CD-
NMMO-G, CD-NMMO-Y, and CD-NMMO-R. (A) A home-made micro-cavity device used in 
single-particle imaging. Up to five samples can be imaged on the same coverslip. Representative 
single-particle emission images of (B) CD-NMMO, (C) CD-NMMO-B, (D) CD-NMMO-Y, (E) 
CD-NMMO-G and (F) CD-NMMO-R as captured by an EMCCD camera. Inset: Individual 
particles form diffraction-limited images and (G) A snapshot of a sample without CDs (control). 
(H) A histogram of emission intensity from 20,000 single CD-NMMOs. (I, J) Representative 
intensity trajectories from single CD-NMMOs, which show a typical single-step photo 
bleaching. Out of 283 CD-NMMOs, approximately 80% displayed stable trajectory (I) and 20% 
displayed transient blinking (J). 
 
The intensity of each particle was analyzed by a Matlab script that allows for semi-
automatic detection of bright spots 217. Because CD-NMMOs’ emission properties depend on 
molecules on their surface, we did not apply any chemical-conjugation strategy to immobilize 
these particles on the glass surface. This would not affect measurement of the brightness at the 
single-particle level because the evanescent field used in TIRF microscopy only excites particles 
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localized within 200 nm distance from the surface. For particles diffusing away from the focus 
during image acquisition, their intensities were then calculated by averaging all frames over their 
prior surface-dwelling time. The representative distribution of individual CD-NMMO particle 
intensity is shown in Figure 13H. For the majority of nanoparticles, we observe a flat emission 
trajectory with minimal photo-blinking (Figure 13I). To determine the photostability and photo 
blinking of individual CD-NMMOs, images were collected using an acquisition time of 600 
frames (60 s). This helped us detect a single-step bleaching behavior. Results from 283 particles 
indicated 80% displayed flat trajectories (Figure 13I) and 20% displayed transient blinking 
lasting less than 1 s (Figure 13J). 
 
 
Figure 14. Single particle analysis of CD-NMMO fractions. (A) Single-particle analysis of the 
brightness of each fraction of CD-NMMO and CD alone. (B) The histogram shows intensity 
distribution of each fraction of particles. Green, yellow, and red fractions show extended peak 
shift to the right (brighter). This extension indicates appearance of particles with enhanced 
fluorescence at single particle level. 
 
To quantitatively determine the brightness of particles in each fraction (CD-NMMO-B, 
CD-NMMO-G, CD-NMMO-Y and CD-NMMO-R), we performed single-particle imaging for 
each fraction (Figure 14). Within the emission spectrum window (500-550 nm & 585-635 nm), 
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the yellow and red fractions appeared brighter than the blue and green fractions as well as CD 
alone. This result confirmed that particles in the yellow and red fractions exhibit significant red-
shift in their emission peak and enhancement of single-particle brightness compared with pristine  
 
 
Figure 15. Intracellular single particle imaging of CD-NMMOs compared with CDs. (A) 
Fluorescence measurement of C32 cells incubated with CD-NMMO (left), CD (middle), and no 
particles (right). Cells were incubated with or without particles, fixed on coverslip, and imaged 
with epi-fluorescence microscopy. The dynamic range for each of the three images in the red 
(top) and green (middle) channels were identical. CD-NMMO incubated cells show significantly 
brighter images. (B) Quantification of cell brightness in both red (left) and green (right) 
fluorescence channels. The base level from control may arise from auto fluorescence of cells. 
The number of cells (n) analyzed in each condition was marked above each bar. For the green 
channel, the excitation wavelength was 450-490 nm and emission wavelength was 500-550 nm. 
For red channel, the excitation wavelength was 540-580 nm and emission wavelength was 600-
675 nm. 
 
Intracellular emission features of CD-NMMOs were investigated in C32 mammalian 
cells (model human melanoma cells). Cells were incubated with CD-NMMOs (1 mg/mL) for 4 h 
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before fixation with 4% paraformaldehyde. Cells incubated with CDs or with no particles were 
used as negative controls (Figure 15). Cells incubated with CD-NMMO showed strongest 
emission in both green and red channels (Figures 15A and 16), indicating the presence of CD-
NMMO’s with different wavelength emissions. For the green channel, the excitation wavelength 
was 450-490 nm and emission wavelength was 500-550 nm. For red channel, the excitation 
wavelength was 540-580 nm and emission wavelength was 600-675 nm. Considering the relative 
strong cellular auto-fluorescence in the green channel, we believe red channel is a better choice 
for intracellular imaging with CD-NMMOs (Figure 15B). 
 
 
Figure 16. Single-cell image analysis of C32 cells incubated with CD-NMMO. For each field 
of view, three channels (Red, Green, Phase Contrast) were used to capture cell image. The region 
of interest (ROI) Manager plugin from FIJI was used to analyze the correlation of fluorescence 
intensities for each channel. 
 
 We also examined the intracellular imaging capacity for each of the fractions of CD-
NMMO. Cells were prepared with the same protocol as mentioned above. We found equally 
efficient CD-NMMO-B, CD-NMMO-G, CD-NMMO-Y, and CD-NMMO-R fractions in DAPI, 
GFP, TX2 and Y5 regions, respectively (Figure 17). Because autofluorescence raises the 
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baseline of fluorescence within the intracellular environment, this work does not cover the scope 
of exploring single-particle imaging within live cells. Ongoing collaborative works in our 
laboratories involve further modification of particle synthesis and imaging technique to enhance 
the signal-to-background ratio of single-particle imaging. Results from these studies will be 
published in the near further. 
 
 
Figure 17. Intracellular image analysis of C32 cells incubated with different fractions of CD-
NMMO. Images of cells treated with CD-NMMO-B, CD-NMMO-G, CD-NMMO-Y, and CD-
NMMO-R acquired under DAPI, GFP, TX2 and Y5 regions, respectively. For each field of view, 
two channels (Color and Phase Contrast) were used to capture cell image. The region of interest 
(ROI) Manager plugin from FIJI was used to analyze the correlation of fluorescence intensities 
for each channel. Scale bar is 30 µm. 
 
The analysis of carbon dots synthesized using different carbon sources and temperatures 
 In this work, CDs were synthesized using four different carbon sources as precursors (α-
d-Glucose 1-phosphate dipotassium salt hydrate, β-d-Glucosamine pentaacetate, D-glucuronic 
acid, and sucrose) at two different synthesis temperatures (200 °C or 150 °C). These CDs were 
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spectroscopically analyzed using bulk-state and single molecule techniques to determine the 
effects of synthesis temperature and carbon source on the photophysical properties of CDs 
(Figure 18). TIRF microscopy was used to acquire single-molecule data, as reported below. 
 
 
Figure 18. Bulk state vs. single particle imaging. (A) Bulk state imaging provides a snap shot 
average of all particles in the sample. The particle blinking in the bulk sample is non-
synchronous, leading to a lack of information about the influence of temperature and 
composition on particle brightness. (B) Single particle imaging captures information about the 
instantaneous intensity of individual particles, allowing for evaluation of particle brightness 
based on individual particle “on” and “off” characteristics. 
 
Interpreting particle brightness by single-particle imaging analysis 
 Bulk measurements of each type of CD showed that they display a wide range of particle 
brightness. To better understand their photophysics, we proceeded to analyze single-particle 
imaging data. By employing a change point data analysis algorithm 218,219, we parsed individual 
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trajectories of each type of particle into “on” and “off” segments. The “on” segment was defined 
by intensity thresholding with the mean value of the darkest segment plus three times the 
standard deviation of that segment. 
 We first determined if different precursor materials and temperatures affect particle 
brightness. There are two parameters that can be used to quantify particle brightness: 1) the 
instantaneous brightness, which is the mean value of intensity in all the “on” segments, and 2) 
the on-time duty cycle, which determines the probability of a particle staying in the emissive 
state during the data acquisition time. We first calculated the instantaneous particle intensity 
(Figure 19A). Although different particles showed different instantaneous intensities, their 
variation is much less than those measured in bulk. This result indicates that, before 
photobleaching, each type of particle has a comparable capacity in emitting photons, an 
observation that seems to contradict the bulk fluorescence measurement. 
 We then further determined the on-time duty cycle of each type of particle. Different 
particles displayed a variety of on-time duty cycles, with the largest duty cycle (20%, β-D-gluc at 
200 °C) almost doubling the smallest one (9%, d-glucuronic acid, 200 °C). We reason that 
fluorescence intensity measured by bulk measurement is determined by both the instantaneous 
intensity and the on-time duty cycle. Indeed, if both factors are considered, the product of 
instantaneous intensity and on-time duty cycle (Figure 19B) much better resembles the bulk 
fluorescence measurement. 
Consideration of both the instantaneous intensity and on-time duty cycle helped us better 
understand the photophysics of different types of particles. For instance, β-D-gluc 200 °C 
displayed the largest instantaneous intensity, as well as the largest on-time duty cycle, therefore 
standing out as the brightest type of particle, consistent with the bulk measurement. On the other 
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hand, although sucrose 150 °C, β-D-gluc 150 °C, and α-D-gluc 200 °C CDs show a similar 
instantaneous intensity, the on-time duty cycle of sucrose 150 °C CDs is only 9%, much less 
than that of β-D-gluc 150 °C (15%) or α-D-gluc 200 °C (14%). Consequently, sucrose 150 °C 
CDs are dimmer than β-D-gluc 150 °C or α-D-gluc 200 °C CDs. Thus, single-particle imaging 
allows for delineation of photophysical mechanisms underlying CD emission. In general, the 
intensity at different synthesis temperatures within the same precursor remains comparable, 
whereas the intensity difference is more significant between different precursor materials. 
 
Figure 19. Single particle analysis of particle brightness. (A) Average particle intensity. All 
particle types have comparable intensities. (B) The product of average intensity and ton duty 
cycle. This appears more comparable to the bulk results than just examining intensity alone. 
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Comparing the photobleaching kinetics between bulk and single-particle measurements 
Bulk photobleaching experiments determined that the photobleaching curves could be 
best fit with a second order exponential, implying that there may be more than one nanoparticle 
population present for each composition and temperature. This led to obtaining two time 
constants for each nanoparticle. In single-particle photobleaching experiments (Figure 20A), the 
photobleaching curves (Figure 20B) were best fit with second order exponential functions. 
However, the single particle time constants (Figure 20C) displayed a trend that was different 
than that of the bulk photobleaching experiments. α-D-gluc and Sucrose CDs had a higher first 
time constant for nanoparticles synthesized at 200 °C than those synthesized at 150 °C, while the 
first time constant for β-D-gluc was lower for nanoparticles synthesized at 200 °C than those 
synthesized at 150 °C. The first time constant did not change very much from one synthesis 
temperature to another for D-glucuronic acid CDs. The second time constant was found to 
decrease with a decrease in synthesis temperature for α-D-gluc and β-D-gluc CDs but increased 
with a decrease in temperature for D-glucuronic acid and sucrose CDs. We note that the bulk 
blinking lifetime is subjected to the "intensity-dependent" artifact. Indeed, densely packed 
particles can modify the local emission properties via e.g. secondary absorption of the emitted 
light. Thus, we focus on quantification of the photophysical properties of CDs at the single-
particle level. 
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Figure 20. Single-particle photobleaching. (A) Single-particle images. (B) Time to 
photobleaching curves for single particles (n=4 for each type). (C) Time constants determined 
form a second order exponential fit of the time to photobleaching curves. 
 
Quantification of CD photoblinking 
The double exponential components in the bleaching lifetime motivates us to pay closer 
attention to particle photophysics. A detailed examination of single-particle trajectories revealed 
two types of photophysical behaviors: 1) a single-step photobleaching and 2) a multiple-step 
photoblinking. Although the emission mechanism underlying these two distinct photophysics 
remains to be elucidated, these two types of optical behaviors may correspond to two types of 
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nanoparticles with distinct photobleaching characteristics. In particular, the single-step bleaching 
should contribute primarily to the fast decay constant, whereas the multiple-step photoblinking 
may account for the prolonged decay constant. 
To better understand the photoblinking of single CDs, we proceeded to analyze their 
distribution of time on (ton) and time off (toff). It has been shown that carbon nanoparticles, like 
other types of nanosized emitters such as quantum dots, display a power-law distribution of ton 
and toff. Indeed, by using a change point algorithm to identify bright and dark states, we assigned 
each segment of the single-particle trajectories to either an “on” or “off” state. Consistent with 
previous studies 220, both ton and toff of nanoparticles showed a linear line in the log-log plot of 
probability vs. durations of ton and toff (Figure 21 A-B). We observed that the slopes of ton and toff 
do not vary significantly over temperature or precursor material (Figure 21 C-D). At first sight, 
this result seems to be contradictory to the observation that the on-time duty cycle between each 
type of particle significantly varies (e.g. from 9% to 20%) because a similar ton slope implies that 
the probability distribution of each on-time duration remains the same. In fact, we can estimate 
the mean duration of on-time by a weighted average from each ton power-law plot. The resulted 
mean values between each particle were indeed very consistent within a small range of 0.42 to 
0.65 seconds, with the maximum value occurring for D-glucuronic acid 150 °C CDs, whose on-
time duty cycle is at the lower end of 10 %. 
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Figure 21. ton and toff photoblinking data based on many single-particle trajectories. Data was 
fit with a power law distribution. (A) Time on distributions for each carbon source and synthesis 
temperature. (B) Time off distributions for each carbon source and synthesis temperature. (C) 
Slopes of time on power law fits. (D) Slopes of time off power law fits. (E) Blinking rate 
(transition rate) for each particle type and synthesis temperature. 
 
This discrepancy can be explained by considering that the on-time duty cycle not only 
depends on the probability distribution of on-time duration but also depends on the blinking 
frequency. Indeed, when we calculated the average blinking frequency for each type of particle, 
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which is defined as the number of blinking events per unit time, we observed a significantly 
different range across all samples, ranging from 0.11 Hz (D-glucuronic acid 150 °C CDs) to 0.26 
Hz (β-D-gluc 200 °C) (Figure 21E). The transition rate of each type of particle quantitatively 
determines the capacity of a particle to recover from an off state to an on state. Thus, for particles 
with similar instantaneous intensity (e.g. α-D-gluc 200 °C, β-D-gluc 150 °C, and sucrose 150 
°C), the increase of particle brightness, which primarily arises from an increase of on-time duty 
cycle, arises from an increase of blinking frequency rather than a change in the distribution of 
on-time duration. Within all four precursor materials, an increase of the synthesis temperature 
leads to a slight increase of the blinking frequency. A summary of all results is provided in 
Figure 22. 
 
 
Figure 22. Summary of results. (A) At the bulk level, a higher synthesis temperature was found 
to lead to a blue-shifted fluorescence, a smaller fluorescence full-width at half maximum 
(FWHM), and a higher quantum yield. (B) At the single-particle level, a higher temperature was 
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Figure 22 (cont.) found to lead to a greater photo-blinking frequency, which led to brighter 
signals from particles. (C) Evaluation at the single-particle level elucidates the effects of 
precursor and synthesis temperature on particle brightness. 
 
We note that the on- and off-time power-law distribution curves down at the timescale of 
10-100 sec. The downward curving of the power-law distribution may indicate competing 
physical processes that interrupt power-law blinking at this timescale. Indeed, this phenomenon 
has also been reported in early studies of quantum dots 221 and nanowires 222. A slight better fit 
can be achieved with a “truncated power law”. Because such modification does not change the 
conceptual description of photoblinking behaviors in this work, we chose to use the ordinary 
power-law distribution. 
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CHAPTER 4: MATERIALS AND METHODS 
 
Optogenetic delineation of receptor tyrosine kinase subcircuits in PC12 cell differentiation 
Experimental model and subject details 
Cell culture 
PC12 cells were cultured in F12K medium supplemented with 15% horse serum, 2.5% FBS, and 
1× Penicillin-Streptomycin solution (complete medium). HEK293T and MDA-MB-231 cells 
were cultured in DMEM medium supplemented with 10% FBS and 1× Penicillin-Streptomycin 
solution. Information about cell line sex is unavailable. 
 
Method details 
Materials 
Phusion DNA polymerase master mix was purchased from NEB (Cat. #M0531). 
Oligonucleotides and gBlock Gene Fragments for cloning were purchased from IDT. In-Fusion 
HD Cloning Plus kit was purchased from Clontech (Cat. #638909). BamHI, NheI, Turbofect 
transfection reagent, protease/phosphatase inhibitors, Bradford reagent, and Calcein AM were 
purchased from Thermo Fisher Scientific (Cat. #FD0054, #FD0973, #R0533, #A32959, #23238, 
#C3100MP). F12K cell media and horse serum were purchased from Gibco (Cat. #21127-022, 
#26050-088). Fetal bovine serum (FBS) was purchased from Sigma-Aldrich (Cat. #12303C). 
Penicillin-Streptomycin solution and DPBS were purchased from Corning (Cat. #30-002-CI, 
#21-031-CV). RIPA lysis buffer was purchased from Millipore (Cat. #20-188). LDS sample 
buffer was purchased from Invitrogen (Cat. #NP0007). Polyacrylamide gels, PVDF membrane, 
and protein standards were purchased from Bio-Rad (Cat. # 4561046, # 1620177, # 1610374). 
78 
 
NGF and antibodies were purchased from Cell Signaling Technology (Cat. #5221, #9101, #9102, 
#2821, #2822, #2956, #7074). Erlotinib was purchased from Selleck Chemicals (Cat. #S7786). 
U73122 and GF 109203X were purchased from Tocris (Cat. #1268, #0741). 
 
Plasmid construction 
Lyn-TrkAICD-AuLOV-GFP was constructed by inserting a gBlock fragment coding the Lyn 
lipidation tag fused to the rat TrkA ICD and AuLOV (Lyn-TrkAICD-AuLOV) into a pEGFP-N1 
vector (Clontech, discontinued; www.addgene.org/vector-database/2491/; linearized by NheI and 
BamHI digestion) using In-Fusion cloning. ICD mutants were generated using overlap extension 
PCR. 
 
Cell culture and transfection 
PC12 cells were cultured in F12K medium supplemented with 15% horse serum, 2.5% FBS, and 
1× Penicillin-Streptomycin solution (complete medium). Cultures were maintained in a standard 
humidified incubator at 37 ºC with 5% CO2. For differentiation assays, 2400 ng of DNA were 
combined with 7.2 μL of Turbofect in 240 μL of serum-free F12K. For western blots, 1200 ng of 
DNA (1200 ng No ICD construct alone or 700 ng No ICD construct + 500 ng ICD-containing 
construct) were combined with 3.6 μL of Turbofect in 120 μL of serum-free F12K. The 
transfection mixtures were incubated at room temperature for 20 minutes prior to adding to cells 
cultured in 35 mm dishes with 500 μL complete medium. For differentiation assays, the 
transfection medium was replaced with 2 mL complete medium after 3 hours of transfection to 
recover cells overnight. For western blots, the transfection medium was replaced with 1 mL 
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serum-free F12K supplemented with 1× Penicillin-Streptomycin solution after 3 hours of 
transfection to serum-starved cells overnight. 
 
PC12 cell differentiation assay 
Transfected and recovered PC12 cells were switched to F12K supplemented with 0.15% horse 
serum, 0.025% FBS, and 1× Penicillin-Streptomycin solution (starvation medium) immediately 
prior to incubating cells on a homemade blue LED light box emitting at 300 μW/cm2. 
Untransfected cells were similarly switched to starvation medium immediately prior to NGF 
treatment. Any inhibitors were added prior to NGF or light treatment. Cells were incubated with 
light for 24 or 44 hours before imaging GFP fluorescence at 10× magnification using a Leica 
DMI8 microscope. Untransfected cells were treated with 1 µM Calcein AM for 10 minutes 
before imaging. Differentiation ratios were calculated as follows: 
 
 
Epi-illumination fluorescence live-cell microscopy 
An epi-illumination inverted fluorescence microscope (Leica DMI8) equipped with a 10×, 100× 
objective (HCX PL FLUOTAR 100×/1.30 oil) and a light-emitting diode illuminator (SOLA SE 
II 365) transfected cells. Green fluorescence was detected using the GFP filter cube (Leica, 
excitation filter 472/30, dichroic mirror 495, and emission filter 520/35). Exposure time for both 
fluorescence channel was 200 ms. 
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Three-dimensional structured illumination microscopy (SIM) 
A total of 2 × 105 MDA-MB-231 cells were seeded into a 35 mm dish containing a 14 mm 
coverslip 24 hours prior to transfection with WT ICD. Super-resolution images were acquired on 
an N-SIM Microscope (Nikon, Tokyo, Japan) equipped with solid-state lasers (405 nm and 488 
nm). Light-induced WT ICD homo-association was stimulated by 405 nm, and SIM images were 
acquired under 488 nm excitation. The cells were exposed to continuous blue light (405 nm) for 
300 seconds. SIM images were captured at the beginning and the end of illumination using an 
electron-multiplying charge coupled device (EMCCD) camera (iXon 897, Andor, USA). To 
reduce photobleaching during SIM image acquisition, laser power (488 nm) was reduced to 
<20% with a minimum exposure time of 200 ms for each image. Images were obtained at 512 × 
512 using Z-stacks with a step size of 0.125 μm. SIM frames were deliberately spaced at 2-s 
intervals. SIM images were analyzed with Nikon Elements and ImageJ. 
 
Western blot 
All transfected and serum-starved PC12 cells were treated with 10 µM Erlotinib (an EGFR 
inhibitor) for 5 minutes prior to illumination to further minimize baseline signaling. Cell were 
then illuminated for 10 minutes using a homemade blue LED light box emitting at 5 mW/cm2. 
For PLCγ and PKC inhibitor experiments, cells were treated with inhibitors for 10 minutes prior 
to light treatment. Following illumination, cells were washed once with 1 mL cold DBPS and 
lysed with 100 μL cold lysis buffer (RIPA + protease/phosphatase inhibitor cocktail). Lysates 
were centrifuged at 17,000 RCF, 4 °C for 10 minutes to pellet cell debris. Purified lysates were 
normalized using Bradford reagent. Normalized samples were mixed with LDS buffer and 
loaded onto 12% polyacrylamide gels. SDS-PAGE was performed at room temperature. Samples 
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were transferred to PVDF membranes overnight at 30 V, 4 °C. Membranes were blocked in 5% 
BSA/TBST for 1 hour at room temperature and probed with the primary and secondary 
antibodies according to company guidelines. Membranes were incubated with ECL substrate and 
imaged using a Bio-Rad ChemiDoc XRS chemiluminescence detector. Signal analysis was 
performed using ImageJ. Activity is defined as the signal ratio of phospho-target/total target. All 
reported activity is normalized to the “dark” activity of each tested condition. 
 
Quantification and statistical analysis 
The p-values were determined by performing two-tailed, unpaired t-test using the GraphPad 
Prism software. The p-values were determined by performing two-tailed, unpaired t-test using 
the GraphPad Prism software. 
 
Single-molecule analysis of fluorescent carbon dots by TIRF microscopy 
The analysis of carbon dots synthesized in the presence of N-methyl morpholine-N-oxide 
Single-particle fluorescence microscopy 
Objective-based total internal reflection fluorescence microscopy (TIRFM) was used for single-
particle imaging. A continuous wavelength (488-nm, Spectral physics) laser was used as the light 
source. An inverted microscope (IX73) equipped with a 100x oil immersion objective (Olympus, 
PlanApo, 100×, N.A. 1.49, oil immersion) was used. The laser beam was then expanded, 
collimated to about 35 mm, and directed into the microscope by 400-mm lens (Thorlabs 
LA1725A). The incident light was directed through the objective via an exciter (FF01-482/563-
25) and a dual-band dichroic filter (Di01-R488/561-25x36). The mean excitation power before 
the objective is about 1.5 mW/cm2. The luminescence photons from individual CDs were 
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collected by the same objective, passing an emitter (FF01-523/610-25) and captured by an 
Electron Multiplying Charge Coupled Device (EMCCD) camera (iXon U797, Andor. 
Technology) The emission filter was designed to have a spectral cut off at 500-548 nm, covering 
the central wavelength of CDs emission at 500 nm.  Thus, experimental observations of emission 
intensity were not affected by potential spectral diffusion of ±10 nm. The sample coverslip was 
secured onto a 2-D stage. Individual nanoparticles were located by raster scanning the stage. An 
exposure time of 100 ms was used. At least ten time-stamped image stacks, each of which 
consists of 600 frames, were taken for each type of particle. 
 
Intracellular imaging of CD-NMMOs with epi-fluorescence microscopy 
An epi-illumination inverted fluorescence microscope (Leica DMI8) equipped with a 100× 
objective (HCX PL FLUOTAR 100×/1.30 oil) and a light-emitting diode illuminator (SOLA SE 
II 365) was used to image CDs in fixed cells. Red fluorescence was detected using the TX2 filter 
cube (Leica, excitation filter 560/40, dichroic mirror 595, and emission filter 645/75). Green 
fluorescence was detected using the GFP filter cube (Leica, excitation filter 472/30, dichroic 
mirror 495, and emission filter 520/35). Exposure time for both fluorescence channel was 200 
ms. 
 
Image analysis for single-particle imaging 
All analysis for single-particle imaging was performed with a custom-written software in 
MATLAB. For each frame, a 7×7-pixel area surrounding each individual fluorescent spot was 
identified. The background level was calculated by averaging the intensity of the peripheral 
pixels excluding the central spot. The intensity of each spot was calculated by averaging all 
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intensities from each pixel within the central spot. The net intensity of each spot was calculated 
by subtracting the background level from that of the central spot. The number of photons was 
calculated by following a formula provided by the vendor. 
 
 
Intracellular image analysis for CD-NMMOs 
The region of interest (ROI) Manager plugin from FIJI was used to analyze the correlation of 
fluorescence intensities for CD-NMMOs in C32 cells. A snapshot of each field of view was 
acquired in three channels (TX2, GFP, and Phase contrast). Manual selection of the cell profile 
was used to enclose each cellular area. An ROI with no cells were selected as the background. 
The average fluorescence intensity in each ROI was measured from the plugin. The fluorescence 
intensity of each cell was calculated by subtracting the background level from that of each cell. 
More than 50 cells were analyzed for each condition. 
 
Imaging CD-NMMO fraction with epi-fluorescence microscopy 
C32 cells were seeded into a multi-cavity PDMS chamber (cavity diameter = 5 mm) placed on 
top of a coverslip 24 hours before treatment. Prior to imaging, cells were incubated with each CD 
fraction (one per cavity) for 15 min at 37oC, 5% CO2, followed by a single wash and submersion 
with DPBS. Live cells were imaged using an inverted epi-illumination fluorescence microscope 
(Leica DMI8) equipped with a 100× objective (HCX PL FLUOTAR 100×/1.30 oil) and a light-
emitting diode illuminator (SOLA SE II 365). Red fluorescence was detected using the Y5 filter 
cube (Leica, excitation filter 620/60, dichroic mirror 660, and emission filter 700/75) with an 
exposure time of 600 ms. Yellow fluorescence was detected using the TX2 filter cube (Leica, 
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excitation filter 560/40, dichroic mirror 595, and emission filter 645/75) with an exposure time of 
300 ms. Green fluorescence was detected using the GFP filter cube (Leica, excitation filter 
472/30, dichroic mirror 495, and emission filter 520/35) with an exposure time of 200 ms. Blue 
fluorescence was detected using the DAPI filter cube (Leica, excitation filter 350/50, dichroic 
mirror 400, and emission filter 460/50) with an exposure time of 100 ms. 
 
The analysis of carbon dots synthesized using different carbon sources and temperatures 
Single-particle photobleaching 
A droplet of 0.2 µL of CD samples was applied to a clean coverslip. The coverslip was then kept 
in a clean biosafety cabinet for 10 min to allow the droplet to dry. Concentrations of each CD 
sample were adjusted so that a layer formed on the surface. To measure the photostability of 
CDs, the coverslip was placed on a home-built TIRF microscope and the boundary of the dried 
smear of CDs was localized. An inverted microscope equipped with a 100x oil immersion 
objective was used. The laser beam was then expanded, collimated to about 35 mm, and directed 
into the microscope by a lens (focal length = 400 mm). The incident light was directed through 
the objective via an exciter and a dual-band dichroic filter. The mean excitation power before the 
objective is 1.5 mW/cm2. For each field of view, 2400 time-stamped images were taken with the 
exposure time of 200 ms per frame, which accounts for a total of 8 min of trajectory. The CD 
signal (inside the boundary) and background (outside the boundary) were extracted by averaging 
a total of 100×100 pixels in the corresponding area. The net signal of CDs was calculated by 
subtracting the background from the gross CD signal for each frame. The emission decaying 
curve was generated by normalizing the maximum net CD signal to 1.0. A script was used to fit 
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the normalized emission decaying curve with a two-component exponential function. The 
photobleaching lifetime was extracted from the fitted values. 
 
Data analysis for single-particle photobleaching 
A MATLAB (Version R2016a) code was generated from the built-in “Curve Fitting Tool” to fit 
the single-particle photobleaching trajectories. A two-component exponential function gave the 
best fit, which generated two time constants,  and , as well as their respective weights and the 
goodness of fit (R2). 
 
Because the variance of the data is larger at the longer timescale than at the shorter timescale, the 
“Weighted Least Square” fit option was used and each data point was weighted by its variance. 
 
Single-particle photoblinking analysis 
Single-particle trajectories were segmented to define the “on” and “off” states based on the 
changepoint analysis. The intensity threshold was defined as the mean of the segment with the 
lowest intensity plus three times the standard deviation of that segment (Mean + 3 σ). A segment 
of the trajectory whose intensity was above this threshold is defined as an “ON” state and its 
duration as ton. An “OFF” state refers to any segment whose intensity was below the threshold 
and its duration as toff. An array of ton and toff was collected from each trajectory and pooled for 
the same type of particle. The power-law distribution of ton and toff were generated by plotting the 
histogram of pooled data. 
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